+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Geography & Life Sciences: Chapter 9182

Chapter 9182 provides bibliographic information on scholary research in geography and in the life sciences.

Pharmacokinetics of tiaprofenic acid in humans: lack of stereoselectivity in plasma using both direct and precolumn derivatization methods. Journal of Pharmaceutical Sciences 85(6): 638-642

Pharmacokinetics of tiaprofenic acid in infants after a single oral dose. International Journal of Clinical Pharmacology and Therapeutics 34(8): 342-344

Pharmacokinetics of tiaprofenic acid in normal rabbits and rabbits subjected to joint immobilisation. Agents & Actions. 39(1-2): 59-68

Pharmacokinetics of tinzaparin (Logiparin): A low molecular weight heparin-after single and repeated intravenous administration in rats. Thrombosis Research 75(4): 453-464

Pharmacokinetics of tiqueside (beta-tigogenin cellobioside) in dogs, rats, rabbits, and monkeys. Journal of Pharmaceutical Sciences 84(1): 12-14

Pharmacokinetics of tirilazad and U-89678 in ischemic stroke patients receiving a loading regimen and maintenance regimen of 10 mg/kg/day of tirilazad. Journal of Clinical Pharmacology 36(9): 809-813

Pharmacokinetics of tirilazad and U-89678, an active, reduced metabolite, following acute head trauma in adults. Journal of Pharmaceutical Sciences 86(4): 434-437

Pharmacokinetics of tirilazad in healthy male subjects at doses above 6 mg/kg/day. International Journal of Clinical Pharmacology and Therapeutics 35(1): 28-32

Pharmacokinetics of tolbutamide following intravenous and oral administrations in rats with obstructive jaundice. Biological & Pharmaceutical Bulletin 17(5): 691-695

Pharmacokinetics of topical beta-adrenergic antagonists in rabbit aqueous humor evaluated with the microdialysis method. Experimental Eye Research 66(4): 487-494

Pharmacokinetics of topical hydrocortisone at plasma level after applications once or twice daily in patients with widespread dermatitis. British Journal Of Dermatology. 133(2): 259-263

Pharmacokinetics of topically applied metronidazole in two different formulations. Skin Pharmacology 10(1): 28-33

Pharmacokinetics of torasemide and its metabolites in end-stage renal disease. European Journal Of Clinical Pharmacology. 47(2): 157-159

Pharmacokinetics of torsemide in patients with decompensated and compensated congestive heart failure. Journal Of Clinical Pharmacology. 38(8): 708-714,.

Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol. Arzneimittel-Forschung 48(5): 436-445

Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories. Arzneimittel-Forschung 48(9): 889-899

Pharmacokinetics of transperitoneal insulin transport. Nephron. 74(2): 283-290

Pharmacokinetics of trapidil in patients with chronic liver disease. Journal of Clinical Pharmacology 36(10): 897-902

Pharmacokinetics of trapidil, an antagonist of platelet derived growth factor, in healthy subjects and in patients with liver cirrhosis. British Journal Of Clinical Pharmacology. 42(4): 443-449

Pharmacokinetics of trazodone during multiple dosing to psychiatric patients. Pharmacology & Toxicology. 72(4-5): 286-289

Pharmacokinetics of triamcinolone acetonide after intravenous, oral, and inhaled administration. Journal of Clinical Pharmacology 35(3): 302-305

Pharmacokinetics of triptorelin after intravenous bolus administration in healthy males and in males with renal or hepatic insufficiency. British Journal Of Clinical Pharmacology. 44(4): 335-341

Pharmacokinetics of tritiated cambendazole in mice in the course of experimental trichinellosis. Helminthologia (Bratislava) 29(4): 207-210

Pharmacokinetics of trofosfamide and its dechloroethylated metabolites. Cancer ChemoTherapy and Pharmacology 40(1): 45-50

Pharmacokinetics of troglitazone, an antidiabetic agent: prediction of in vivo stereoselective sulfation and glucuronidation from in vitro data. Journal of Pharmacology and Experimental Therapeutics 280(3): 1392-1400

Pharmacokinetics of tropatepine in healthy volunteers. Clinical Drug Investigation. 14(1): 53-60

Pharmacokinetics of trovafloxacin (CP-99,219), a new quinolone, in rats, dogs, and monkeys. Antimicrobial Agents and ChemoTherapy 40(3): 561-566

Pharmacokinetics of two cyclosporine formulations using FPIA and HPLC assay in volunteers. Archives Of Pharmacal Research (seoul). 18(6): 385-390

Pharmacokinetics of two enteric-coated ketoprofen products in humans with or without coadministration of omeprazole and comparison with dissolution findings. Pharmaceutical Research (new York). 11(11): 1669-1672

Pharmacokinetics of two human menopausal gonadotrophin preparations after single intravenous administration during pituitary suppression. Human Reproduction 10(6): 1367-1372

Pharmacokinetics of two multiple-dosing regimens of D0870 in human immunodeficiency virus-positive patients: a phase I study. Antimicrobial Agents and ChemoTherapy 42(4): 903-906

Pharmacokinetics of two new s-chloroethylnitrosoureas in cancer patients submitted to phase II clinical trials. Drug Investigation 7(5): 234-243

Pharmacokinetics of two partial benzodiazepine receptor agonistic beta-carboline derivatives in healthy volunteers. Arzneimittel-Forschung 43(5): 511-515

Pharmacokinetics of undiluted or diluted high-dose etoposide with or without busulfan administered to patients with hematologic malignancies. Journal of Clinical Oncology 12(7): 1468-1474

Pharmacokinetics of valproate after multiple-dose oral and intravenous infusion administration: gastrointestinal-related diurnal variation. Journal of Clinical Pharmacology 34(7): 754-759

Pharmacokinetics of valproic acid after oral administration of sustained-release granules of sodium valproate in human. Yakuzaigaku 54(1): 55-60

Pharmacokinetics of valproic acid in patients with juvenile myoclonic epilepsy on monotherapy. Therapeutic Drug Monitoring 19(2): 153-159

Pharmacokinetics of valsartan in patients with liver disease. Clinical Pharmacology and Therapeutics 62(3): 272-278

Pharmacokinetics of vancomycin in adult cystic fibrosis patients. Antimicrobial Agents and ChemoTherapy 40(1): 186-190

Pharmacokinetics of vancomycin in critically ill infants undergoing extracorporeal membrane oxygenation. Antimicrobial Agents and ChemoTherapy 40(5): 1139-1142

Pharmacokinetics of vancomycin in patients with severely impaired renal function. International Journal of Clinical Pharmacology and Therapeutics 34(2): 71-75

Pharmacokinetics of vasoactive substances administered into the human corpus cavernosum. Journal of Urology 151(5): 1227-1230

Pharmacokinetics of venlafaxine and O-desmethylvenlafaxine in laboratory animals. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 24(4): 315-327

Pharmacokinetics of venom neural growth factor in rats and its distribution in peripheral neural tissues. Zhongguo Yaolixue Yu Dulixue Zazhi 12(3): 215-220, Aug

Pharmacokinetics of verapamil in overdose. Human & Experimental Toxicology 16(1): 35-37

Pharmacokinetics of vigabatrin following single and multiple oral doses in normal volunteers. Journal of Clinical Pharmacology 33(5): 458-462

Pharmacokinetics of vincristine in children and adolescents with acute lymphocytic leukemia. Journal Of Pediatrics. 125(4): 642-649

Pharmacokinetics of vinorelbine in patients with liver metastases. Clinical Pharmacology and Therapeutics 59(1): 32-40

Pharmacokinetics of von Willebrand factor and factor VIIIC in patients with severe von Willebrand disease (type 3 VWD): Estimation of the rate of factor VIII synthesis. British Journal of Haematology 94(4): 740-745

Pharmacokinetics of weekly transdermal estradiol controlled delivery system in postmenopausal Chinese. Zhongguo Yao Li Xue Bao 17(5): 407-410

Pharmacokinetics of wood creosote: glucuronic acid and sulfate conjugation of phenolic compounds. Pharmacology 51(3): 195-204

Pharmacokinetics of zenarestat, an aldose reductase inhibitor, in male and female diabetic rats. Drug Metabolism and Disposition: the Biological Fate of Chemicals 21(4): 677-681

Pharmacokinetics of zidovudine after the initial single dose and during chronic-dose therapy in HIV-infected patients. British Journal Of Clinical Pharmacology. 36(2): 128-131

Pharmacokinetics of zidovudine alone and in combination with oxazepam in the HIV infected patient. Journal of Acquired Immune Deficiency Syndromes 6(1): 56-60

Pharmacokinetics of zidovudine and acetaminophen in a patient on chronic acetaminophen therapy. Annals of PharmacoTherapy 28(3): 327-330

Pharmacokinetics of zidovudine and didanosine during combination therapy. Antiviral Research. 27(4): 419-424

Pharmacokinetics of zidovudine and dideoxyinosine alone and in combination in children with HIV infection. British Journal Of Clinical Pharmacology. 39(5): 527-530

Pharmacokinetics of zidovudine and dideoxyinosine alone and in combination in patients with the acquired immunodeficiency syndrome. British Journal Of Clinical Pharmacology. 37(5): 421-426

Pharmacokinetics of zidovudine in HIV-infected patients with end-stage renal disease. Blood Purification 13(6): 340-346

Pharmacokinetics of zidovudine in HIV-positive patients with liver disease. Journal of Clinical Pharmacology 34(7): 782-786

Pharmacokinetics of zidovudine in children with symptomatic HIV infection. Drug Investigation. 7(3): 143-147

Pharmacokinetics of zidovudine phosphorylation in peripheral blood mononuclear cells from patients infected with human immunodeficiency virus. Antimicrobial Agents & Chemotherapy. 38(7): 1541-1547

Pharmacokinetics of zileuton and its metabolites in patients with renal impairment. Journal of Clinical Pharmacology 37(5): 395-404

Pharmacokinetics of zinc acexamate (ZAC) in rats. Yao Xue Xue Bao 30(1): 17-20

Pharmacokinetics of zinc glutamate solution in rabbits. Chinese Journal of Pharmaceuticals 23(3): 114-116

Pharmacokinetics of zinc-indomethacin capsules and suspension. Chinese Journal of Pharmaceuticals 24(8): 360-362

Pharmacokinetics of zopiclone and its enantiomers in Caucasian young healthy volunteers. Drug Metabolism & Disposition. 21(6): 1125-1128

Pharmacokinetics of zotepine and various factors affecting that of zotepine. Nihon Shinkei Seishin Yakurigaku Zasshi 16(2): 49-52

Pharmacokinetics profile of the induction dose of propofol in patients with severe burns. Clinical Drug Investigation 14(4): 314-320

Pharmacokinetics properties prediction of some oral hypoglycemic agents using QSAR relationship. Anales de la Real Academia de Farmacia 58(4): 551-562

Pharmacokinetics relevant to the anti-carcinogenic and anti-tumor activities of glucarate and the synergistic combination of glucarate:retinoid in the rat. Biochemical Pharmacology 47(9): 1655-1660

Pharmacokinetics study of (S)-( sbd )-2-(N-propyl-N-(2-thienylethyl)amino)-5-hydroxytetraline infusion in cynomolgus monkeys. Journal of Pharmaceutical Sciences 83(5): 758-760

Pharmacokinetics study of 14C-moxisylyte after percutaneous application to hairless rat. Arzneimittel-Forschung 45(11): 1161-1165

Pharmacokinetics study of fleroxacin in healthy volunteers. Zhongguo Kangshengsu Zazhi 21(5): 384-387

Pharmacokinetics study on three fluoroquinolones. Chinese Journal of Antibiotics 18(5): 334-337

Pharmacokinetics, biodistribution, and dosimetry of specific and control radiolabeled monoclonal antibodies in patients with primary head and neck squamous cell carcinoma. Cancer Research 55(5): 1060-1069

Pharmacokinetics, Metabolism and Clinical Effect of Ifosfamide in Breast Cancer Patients. European Journal Of Cancer. 31a(1): 69-76

Pharmacokinetics, Oral Bioavailability, and Metabolism in Mice and Cynomolgus Monkeys of (2'R,5'S-)-cis-5-Fluoro-1-(2-(Hydroxymethyl)-1,3-Oxathiolan-5-yl) Cytosine, an Agent Active against Human Immunodeficiency Virus and Human Hepatitis B Virus. Antimicrobial Agents and Chemotherapy 38(12): 2722-2729

Pharmacokinetics, tissue distribution, and stability of antisense oligodeoxynucleotide phosphorothioate ISIS 3466 in mice. Oncology Research 6(6): 243-249

Pharmacokinetics, toxicity, and efficacy of liposomal capreomycin in disseminated Mycobacterium avium beige mouse model. Antimicrobial Agents and ChemoTherapy 38(12): 2695-2701

Pharmacokinetics, absolute bioavailability, and absorption characteristics of lamivudine. Journal Of Clinical Pharmacology. 35(12): 1174-1180

Pharmacokinetics, absolute bioavailability, and disposition of (14C)nefazodone in humans. Drug Metabolism and Disposition 24(1): 91-95

Pharmacokinetics, absolute bioavailability, and disposition of carbon-14 nefazodone in the dog. Drug Metabolism & Disposition 21(3): 502-507

Pharmacokinetics, absorption, distribution and disposition of (125I)-oligotide following intravenous or oral administration in the rat. Thrombosis Research 85(6): 445-453

Pharmacokinetics, absorption, distribution and disposition of iodine-125 defibrotide following intravenous or oral administration in the rat. Thrombosis Research 70(1): 77-90

Pharmacokinetics, antifolate activity and tissue distribution of PT523 in SCC VII tumor-bearing mice. Cancer ChemoTherapy and Pharmacology 42(4): 300-306

Pharmacokinetics, bioavailability and tissue residues of (14C)isometamidium in non-infected and Trypanosoma congolense-infected Boran cattle. Acta Tropica 61(4): 277-292

Pharmacokinetics, bioavailability, and safety of montelukast sodium (MK-0476) in healthy males and females. Pharmaceutical Research (New York) 13(3): 445-448

Pharmacokinetics, bioavailability, metabolism, and tissue distribution of cidofovir (HPMPC) and cyclic HPMPC in rats. Drug Metabolism and Disposition: the Biological Fate of Chemicals 24(7): 745-752

Pharmacokinetics, bioavailability, plasma protein binding and disposition of nalidixic acid in rainbow trout (Oncorhynchus mykiss). Xenobiotica; the Fate of Foreign Compounds in Biological Systems 23(9): 961-972

Pharmacokinetics, biodistribution and biological effects of intravenously administered bispecific monoclonal antibody OC/TR F(ab')2 in ovarian carcinoma patients. International Journal of Cancer 66(4): 477-483

Pharmacokinetics, biodistribution and dosimetry of 99mTc-labeled anti-human epidermal growth factor receptor humanized monoclonal antibody R3 in rats. Nuclear Medicine & Biology. 25(1): 17-23,.

Pharmacokinetics, biodistribution and therapeutic efficacy of doxorubicin encapsulated in Stealth liposomes (Doxil). Journal of Liposome Research 4(1): 667-687

Pharmacokinetics, biodistribution and tumor localization of two anti-human B-cell chronic lymphocytic leukemia monoclonal antibodies and their F(ab)'2 fragments in a xenograft model. Cancer Letters 76(1): 31-44

Pharmacokinetics, bioefficacy, and safety of sublingual testosterone cyclodextrin in hypogonadal men: comparison to testosterone enanthate--a clinical research center study. Journal of Clinical Endocrinology and Metabolism 80(12): 3567-3575

Pharmacokinetics, biological effects, and distribution of (1fwdarw3)-beta-D-glucan in blood and organs in rabbits. Mediators of Inflammation 6(4): 279-283

Pharmacokinetics, cell toxicity, antitumor activity and spleen/blood cell toxicity of aclarubicin-entrapped liposomes. Yakhak Hoeji 42(3): 275-283, June

Pharmacokinetics, cerebrospinal fluid penetration, and metabolism of piroxantrone in the Rhesus monkey. Investigational New Drugs. 11(4): 255-261

Pharmacokinetics, disposition and biotransformation of (14C)-radiolabelled valsartan in healthy male volunteers after a single oral dose. Xenobiotica 27(1): 59-71

Pharmacokinetics, disposition and metabolism of 546C88 (L-NG-methylarginine hydrochloride) in rat and dog. Xenobiotica 27(12): 1259-1271

Pharmacokinetics, dose adjustments, and 6-mercaptopurine/methotrexate drug interactions in two patients with thiopurine methyltransferase deficiency. Acta Paediatrica 87(1): 108-111

Pharmacokinetics, dose proportionality, and tolerability of gadobutrol after single intravenous injection in healthy volunteers. Investigative Radiology 29(7): 709-715

Pharmacokinetics, dosimetry and toxicity of holmium-166-DOTMP for bone marrow ablation in multiple myeloma. Journal of Nuclear Medicine 36(5): 730-737

Pharmacokinetics, dosimetry and toxicity of rhenium-188-labeled anti-carcinoembryonic antigen monoclonal antibody, MN-14, in gastrointestinal cancer. Journal of Nuclear Medicine 39(1): 34-42

Pharmacokinetics, effects on renal function, and potentiation of atracurium-induced neuromuscular blockade after administration of a high dose of gentamicin in isoflurane-anesthetized dogs. American Journal of Veterinary Research 57(11): 1623-1626

Pharmacokinetics, enantiomer interconversion, and metabolism of R-apomorphine in patients with idiopathic Parkinson's disease. Clinical Neuropharmacology 21(3): 159-168

Pharmacokinetics, hydrolysis and aromatisation of norethisterone-3-oxime in female cynomolgus monkey. European Journal Of Drug Metabolism & Pharmacokinetics. 17(4): 281-291

Pharmacokinetics, immunogenicity, and efficacy of dimeric TNFR binding proteins in healthy and bacteremic baboon. Journal of Applied Physiology 84(4): 1119-1130

Pharmacokinetics, intramuscular bio-availability, and bioequivalence of amoxycillin in donkeys. Zentralblatt für Veterinarmedizin. Reihe B. Journal of Veterinary Medicine. Series B 42(5): 284-292

Pharmacokinetics, mass balance, and induction potential of a novel GABA uptake inhibitor, CI-966 hydrochloride, in laboratory animals. Pharmaceutical Research (New York) 10(10): 1442-1445

Pharmacokinetics, metabolism and pharmacodynamics of a benzimidazole angiotensin II type 1 receptor antagonist in the beagle dog and cynomologus monkey. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 28(1): 77-91

Pharmacokinetics, metabolism, and elimination of a 20-mer phosphorothioate oligodeoxynucleotide (CGP 69846A) after intravenous and subcutaneous administration. Biochemical Pharmacology 54(6): 657-668

Pharmacokinetics, oral bioavailability, and metabolic disposition in rats of (-)-cis-5-fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine, a nucleoside analog active against human immunodeficiency virus and hepatitis B virus. Antimicrobial Agents and Chemotherapy 37(11): 2285-2292

Pharmacokinetics, pharmacodynamic and side effects of B2 agonists. Prensa Medica Argentina 82(9): 878-884

Pharmacokinetics, pharmacodynamics and bioavailability of the ACE inhibitor ramipril. European Journal Of Clinical Pharmacology. 47(6): 513-518

Pharmacokinetics, pharmacodynamics and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue (Lys(B28),Pro(B29)) in IDDM. Diabetologia 37(7): 713-720

Pharmacokinetics, pharmacodynamics and tolerability of a potent, non-peptidic, GP IIb/IIIa receptor antagonist following multiple oral administrations of a prodrug form. Thrombosis and Haemostasis 79(1): 169-176

Pharmacokinetics, pharmacodynamics, and tolerability of tolcapone: a review of early studies in volunteers. Neurology 50(5 Suppl 5): S31-S38

Pharmacokinetics, pharmacodynamics, and prediction of developmental abnormalities. Reproductive Toxicology. 11(2-3): 413-416

Pharmacokinetics, pharmacodynamics, and safety of metrifonate in patients with Alzheimer's disease. Journal of Clinical Pharmacology 38(3): 236-245

Pharmacokinetics, pharmacodynamics, and tolerability of cabergoline, a prolactin-lowering drug, after administration of increasing oral doses (0.5, 1.0, and 1.5 milligrams) in healthy male volunteers. Journal of Clinical Endocrinology and Metabolism 80(3): 841-845

Pharmacokinetics, pharmacodynamics, long-term efficacy and safety of oral 1-deamino-8-D-arginine vasopressin in adult patients with central diabetes insipidus. British Journal Of Clinical Pharmacology. 42(3): 379-385

Pharmacokinetics, pharmacological and anti-tumour effects of the specific anti-oestrogen ICI 182780 in women with advanced breast cancer. British Journal of Cancer 74(2): 300-308

Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats. Arzneimittel-Forschung 48(4): 371-378

Pharmacokinetics, safety and bioavailability of HPMPC (cidofovir) in human immunodeficiency virus-infected subjects. Antiviral Research 29(2-3): 153-161

Pharmacokinetics, safety and tolerability of the orally administered receptor antagonist of cysteinyl-leukotrienes BAY x 7195 in single-dose escalation studies. International Journal of Clinical Pharmacology and Therapeutics 33(10): 573-579

Pharmacokinetics, safety, and pharmacologic effects of OPC-21268, a nonpeptide orally active vasopressin V1 receptor antagonist, in humans. Journal of Clinical Pharmacology 33(3): 230-238

Pharmacokinetics, safety, and tolerability of flosequinan in patients with hepatic dysfunction. Journal Of Pharmaceutical Sciences. 83(3): 382-385

Pharmacokinetics, science or fiction?. Pharmacological Research 33(4-5): 227-233

Pharmacokinetics, thrombogenicity and safety of a double-treated prothrombin complex concentrate. Thrombosis Research. 71(3): 175-184

Pharmacokinetics, tissue distribution and biliary excretion of FT-ADM after intravenous administration of DA-125, a prodrug of FT-ADM to dogs: A new adriamycin analog containing fluorine. International Journal of Pharmaceutics (Amsterdam) 109(2): 181-187

Pharmacokinetics, tissue distribution and in vivo antitumor effects of the antimelanoma immunotoxin ZME-gelonin. Cancer Immunology Immunotherapy. 40(5): 339-345

Pharmacokinetics, tissue distribution and metabolism of intravenously administered digalactosyldiacylglycerol and monogalactosyldiacylglycerol in the rat. Journal of Liposome Research 6(4): 737-753

Pharmacokinetics, tissue distribution, and excretion of cis-malonato((4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1,3-dioxolane)platinum(II) in dogs. Drug Metabolism and Disposition 23(11): 1280-1285

Pharmacokinetics, tissue distribution, and expression efficiency of plasmid (33P)DNA following intravenous administration of DNA/cationic lipid complexes in mice: Use of a novel radionuclide approach. Journal of Pharmaceutical Sciences 85(6): 612-618

Pharmacokinetics, tissue distribution, and safety of P-ethoxy oligonucleotides incorporated in liposomes. Journal Of Liposome Research. 8(2): 251-264,

Pharmacokinetics, tolerability, and preliminary efficacy of human anti-Pseudomonas aeruginosa monoclonal antibodies in pneumonia and burn infection patients. Hybridoma 16(5): 413-420

Pharmacokinetics, toxicity, side effects, receptor affinities and in vitro radiosensitizing effects of the novel metoclopramide formulations, Sensamide and Neu-Sensamide. Pharmacology & Toxicology. 80(5): 231-239

Pharmacokinetics-Pharmacodynamic Modelling of the Cardiovascular Effects of R- and S-N-6-Phenylisopropyladenosine in Conscious Normotensive Rats. Journal of Pharmacology & Experimental Therapeutics 273(1): 405-414

Pharmacokinetics-pharmacodynamic modeling between pinacidil or pinacidil-N-oxide plasma levels and systemic and regional hemodynamic effects in healthy volunteers. Fundamental & Clinical Pharmacology 8(5): 437-445

Pharmacokinetics/dynamics of 5c8, a monoclonal antibody to CD154 (CD40 ligand) suppression of an immune response in monkeys. Journal of Pharmacology and Experimental Therapeutics 286(2): 925-930

Pharmacologic Profile of the Dihydropyrimidine Calcium Channel Blockers SQ 32,547 and SQ 32,946. Journal of Cardiovascular Pharmacology 26(2): 289-294

Pharmacologic Properties of the Swelling-Induced Chloride Current of Dog Atrial Myocytes. Journal Of Cardiovascular Electrophysiology. 5(12): 1006-1016

Pharmacologic treatment of abnormal ion transport in the airway epithelium in cystic fibrosis. Chest 107(2 Suppl): 71s-76s

Pharmacologic actions of subtype-selective and novel GABAergic ligands in rat lines with differential sensitivity to ethanol. Pharmacology Biochemistry & Behavior. 53(3): 723-730

Pharmacologic activation of limbic structures and neuroimaging studies of emotions. Journal of Clinical Psychiatry 58 Suppl 16: 13-15

Pharmacologic activation of the human coronary microcirculation in vitro: endothelium-dependent dilation and differential responses to acetylcholine. Cardiovascular Research 38(3): 744-750

Pharmacologic activity of Quassia amara (Simarubaceae) aqueous wood extract on albino rats and mice. Revista de Biologia Tropical 44-45(3-1): 47-50

Pharmacologic alteration of the perception of being awake or asleep. Sleep 16(7): 641-646

Pharmacologic alterations in human type I atrial flutter cycle length and monophasic action potential duration: Evidence of a fully excitable gap in the reentrant circuit. Journal of the American College of Cardiology 27(2): 453-461

Pharmacologic analysis of the secretory function of the liver under altered activity of microsomal enzymes. Likars'ka Sprava 0(7-9): 65-68

Pharmacologic and clinical comparison of cefaclor in immediate-release capsule and extended-release tablet forms. Clinical Therapeutics. : 617-625

Pharmacologic and dietary therapies in epilepsy: conventional treatments and recent advances. Southern Medical Journal 90(5): 471-480

Pharmacologic and hemodynamic effects of combined beta-agonist stimulation and phosphodiesterase inhibition in the failing human heart. Chest 108(6): 1524-1532

Pharmacologic and neurochemical evidence for the activation of capsaicin-sensitive sensory nerves by lipoxin A4 in guinea pig bronchus. American Review of Respiratory Disease 146(4): 930-934

Pharmacologic and pharmacodynamic effects of the selective low Km cyclic AMP phosphodiesterase III inhibitors WIN 63291 and WIN 62582. Journal of Cardiovascular Pharmacology 24(3): 403-410

Pharmacologic and pharmacokinetic profile of class III antiarrhythmic drugs. American Journal Of Cardiology. 80(8a): 16g-23g

Pharmacologic and pharmacokinetic profile of mibefradil, a T- and L-type calcium channel antagonist. American Journal Of Cardiology. 80(4b): 4c-11c

Pharmacologic and psychologic interventions for procedural pain. Pediatrics 102(1 Pt 1): 59-66

Pharmacologic and radioligand binding studies of 1,4-dihydropyridines in rat cardiac and vascular preparations: stereoselectivity and voltage dependence of antagonist and activator interactions. Molecular Pharmacology 41(3): 535-541

Pharmacologic and surgical enhancement of composite graft survival. Archives of Otolaryngology--Head & Neck Surgery 119(3): 313-319

Pharmacologic approach of hypoxemia in ARDS patients. Intensivmedizin und Notfallmedizin 34(3): 179-197

Pharmacologic approach to management of agitation associated with dementia. Journal of Clinical Psychiatry 55 Suppl: 13-17

Pharmacologic atrial natriuretic peptide reduces human leg capillary filtration. Journal of Cardiovascular Pharmacology 26(3): 414-419

Pharmacologic challenges in Alzheimer disease and normal controls: cognitive modeling in humans. Alzheimer Disease and Associated Disorders 11 Suppl 4: S23-S26

Pharmacologic characteristics of a medullary hyperalgesic center. Journal of Pharmacology and Experimental Therapeutics 265(1): 286-293

Pharmacologic characteristics of excitatory gamma-amino-butyric acid (GABA) receptors in a snail neuron. General Pharmacology 28(1): 45-53

Pharmacologic characteristics of potentiation of 5-HT3 receptors by alcohols and diethyl ether in NCB-20 neuroblastoma cells. Journal of Pharmacology and Experimental Therapeutics 278(2): 732-740

Pharmacologic characteristics of rabbit esophageal muscularis mucosae in vitro. Digestive Diseases & Sciences. 42(12): 2537-2546,.

Pharmacologic characterization of (3H)dopamine and (3H)spiperone binding in mouse cerebellum. General Pharmacology 25(1): 131-137

Pharmacologic characterization of a novel histamine receptor on human eosinophils. American Journal of Respiratory and Critical Care Medicine 149(6): 1506-1511

Pharmacologic characterization of endothelin receptor responses in the isolated perfused rat lung. American Journal of Respiratory and Critical Care Medicine 152(5 Pt 1): 1449-1460

Pharmacologic characterization of melatonin-mediated phosphoinositide hydrolysis in pigeon brain. Journal of Pineal Research 17(1): 33-38

Pharmacologic characterization of opioid peptide release from chromaffin cell transplants using a brain slice superfusion method. Experimental Brain Research. 95(3): 381-387

Pharmacologic characterization of refilling inositol 1,4,5-trisphosphate-sensitive Ca-2+ stores in NG108-15 cells. Brain Research. 704(1): 10-18

Pharmacologic characterization of the human 5-hydroxytryptamine2B receptor: evidence for species differences. Journal of Pharmacology and Experimental Therapeutics 276(2): 720-727

Pharmacologic characterization of the inositol trisphosphate receptor in rat pancreas. Pancreas 9(5): 591-598

Pharmacologic characterization of the novel ligand tritiated 4,5-leucyl-9-neurokinin-A binding to NK-2 receptors on hamster urinary bladder membranes. Neuropeptides 23(2): 121-130

Pharmacologic characterization of the novel, orally available endothelin-A--selective antagonist SB 247083. Journal of Cardiovascular Pharmacology 31 Suppl 1: S273-S276

Pharmacologic circumvention of multidrug resistance. Cytotechnology. 12(1-3): 171-212

Pharmacologic considerations for antiviral drug development. Annals of PharmacoTherapy 30(9): 972-977

Pharmacologic control of histamine release from human basophils induced by platelet-activating factor. International Archives of Allergy and Immunology 102(4): 383-390

Pharmacologic control of intracellular signaling pathways: from research to therapy. Journal of Cardiovascular Pharmacology 25 Suppl 2: S106-S113

Pharmacologic controversy of CNS stimulants in Gilles de la Tourette's syndrome. Clinical Neuropharmacology 15(5): 408-425

Pharmacologic differentiation between endothelium-dependent relaxations sensitive and resistant to nitro-L-arginine in coronary arteries. Journal of Cardiovascular Pharmacology 23(5): 747-756

Pharmacologic dilatation of the internal mammary artery during coronary bypass grafting. Journal of Thoracic and Cardiovascular Surgery 107(6): 1440-1444

Pharmacologic effect of imipramine, paroxetine, and sertraline on 35 percent carbon dioxide hypersensitivity in panic patients: A double-blind, random, placebo-controlled study. Journal of Clinical Psychopharmacology 17(2): 97-101

Pharmacologic effect of toloxatone on reactivity to the 35 percent carbon dioxide challenge: A single-blind, random, placebo-controlled study. Journal of Clinical Psychopharmacology 14(6): 414-418

Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery. Proceedings of the National Academy of Sciences of the United States of America 90(7): 2618-2622

Pharmacologic effects of cisplatin microspheres on peritoneal carcinomatosis in rodents. Cancer (philadelphia). 71(3): 844-850

Pharmacologic effects of paclitaxel in human bladder tumors. Cancer ChemoTherapy and Pharmacology 41(1): 69-74

Pharmacologic electroencephalographic suppression during cardiopulmonary bypass: a comparison of thiopental and isoflurane. Anesthesia and Analgesia 86(2): 246-251

Pharmacologic enhancement of random skin flap survival by prostaglandin E2. Archives of Otolaryngology--Head & Neck Surgery 120(1): 56-60

Pharmacologic evaluation of megestrol acetate oral suspension in cachectic AIDS patients. Journal of Acquired Immune Deficiency Syndromes 7(6): 580-586

Pharmacologic evaluation of the calcitonin analogue SB 205614 in models of osteoclastic bone resorption in vitro and in vivo: Comparison with salmon calcitonin and elcatonin. Bone (New York) 16(4): 435-444

Pharmacologic evaluation of the discriminative stimulus of metachlorophenylpiperazine. Pharmacology Biochemistry & Behavior. 53(1): 107-114

Pharmacologic evidence for 5-HT1A receptors associated with human retinal pigment epithelial cells in culture. Investigative Ophthalmology & Visual Science 38(2): 510-519

Pharmacologic evidence for involvement of phospholipase C in pemphigus IgG-induced inositol 1,4,5-trisphosphate generation, intracellular calcium increase, and plasminogen activator secretion in DJM-1 cells, a squamous cell carcinoma line. Journal of Investigative Dermatology 105(3): 329-333

Pharmacologic evidence for the presence of three functional endothelin receptor subtypes in rabbit saphenous vein. Journal of Cardiovascular Pharmacology 26 Suppl 3: S163-S168

Pharmacologic evidence for the specificity of the phosphoramidon-sensitive endothelin-converting enzyme for big endothelin-1. Journal of Cardiovascular Pharmacology 22 Suppl 8: S85-S89

Pharmacologic evidence that spinal muscarinic analgesia is mediated by an L-arginine/nitric oxide/cyclic GMP cascade in rats. Journal of Pharmacology and Experimental Therapeutics 271(2): 601-608

Pharmacologic hemodynamic support in massive pulmonary embolism. Chest 111(1): 218-224

Pharmacologic hemoglobin reversal: The importance of lipid intermediaries and the proposed involvement of the cAMP and phosphatidylinositol second messenger systems. Hemoglobin 22(3): 245-261

Pharmacologic heterogeneity of human lung and colon cells: Effect of terfenadine and cetirizine. Allergy (Copenhagen) 50(4): 362-365

Pharmacologic induction of posterior vitreous detachment in the rabbit. Archives of Ophthalmology 111(6): 849-854

Pharmacologic inhibition of collagen in an experimental model of subglottic stenosis. Annals of Otology, Rhinology, and Laryngology 107(4): 275-279

Pharmacologic inhibition of transglutaminase-induced cross-linking of Alzheimer's amyloid beta-peptide. Life Sciences 60(25): 2323-2332

Pharmacologic inhibition of twin-pulse facilitation of release of transmitter quanta at the mouse neuromuscular junction. General Pharmacology. 28(2): 341-343

Pharmacologic inhibitors of tumor necrosis factor production exert differential effects in lethal endotoxemia and in infection with live microorganisms in mice. Journal Of Infectious Diseases. 171(2): 393-399

Pharmacologic intervention and treatment of childhood seizure disorders: Relative efficacy and safety of antiepileptic drugs. Epilepsia 35(SUPPL. 2): S18-S23

Pharmacologic intervention can reestablish baseline hemodynamic parameters during laparoscopy. Surgery 116(4): 733-9; Discussion 739-41

Pharmacologic intervention of skin vasospasm and ischemic necrosis in pigs. Journal of Cardiovascular Pharmacology 21(1): 163-171

Pharmacologic intolerance reaction after intravenous injection of morphine. Allergologie 20(7): 345-346, July

Pharmacologic levels of heparin do not destabilize neonatal parenteral nutrition. Jpen. Journal of Parenteral and Enteral Nutrition 22(5): 311-314

Pharmacologic limits of the protective effect of polyaspartic acid on experimental gentamicin nephrotoxicity. Antimicrobial Agents and ChemoTherapy 37(2): 347-348

Pharmacologic management of atrial fibrillation. Journal Of Cardiovascular Electrophysiology. 8(7): 818-829

Pharmacologic management of movement disorder after midbrain haemorrhage. Brain Injury 12(7): 623-628

Pharmacologic management of obsessive-compulsive disorder. Southern Medical Journal 87(3): 310-321

Pharmacologic management of postdural puncture headache. Annals of PharmacoTherapy 30(7-8): 831-839

Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines. American Journal of Psychiatry 153(5): 592-606

Pharmacologic management of supraventricular tachycardias in children. Part 1: Wolff-Parkinson-White and atrioventricular nodal reentry. Annals of PharmacoTherapy 31(10): 1227-1243

Pharmacologic manipulation of a four day murine delayed type hypersensitivity model. Agents & Actions. 38(1-2): 116-121

Pharmacologic modification of tumor blood flow and interstitial fluid pressure in a human tumor xenograft: network analysis and mechanistic interpretation. Microvascular Research 50(3): 429-443

Pharmacologic modulation of antigen-induced pulmonary responses in the perfused guinea pig lung. American Review of Respiratory Disease 147(2): 262-269

Pharmacologic modulation of delayed-type hypersensitivity in mice. Arzneimittel-Forschung 46(9): 884-886

Pharmacologic modulation of pulmonary vascular permeability during air embolism. Undersea & Hyperbaric Medicine 24(4): 315-321

Pharmacologic modulation of reduced glutathione circadian rhythms with buthionine sulfoximine: relationship with cisplatin toxicity in mice. Toxicology and Applied Pharmacology 143(2): 281-290

Pharmacologic modulation of salt and water in the airway epithelium in cystic fibrosis. American Journal of Respiratory and Critical Care Medicine 151(3 Pt 2): S65-S69

Pharmacologic modulation of the autonomic nervous system in the prevention of sudden cardiac death: A study with propranolol, methacholine and oxotremorine in conscious dogs with a healed myocardial infarction. Journal of the American College of Cardiology 22(1): 283-290

Pharmacologic modulation of the cutaneous vasculature in the isolated perfused porcine skin flap. Journal Of Pharmaceutical Sciences. 83(12): 1682-1689

Pharmacologic modulation of the influence of the epithelium on immunologic- and non-immunologic-induced histamine release and contraction in guinea pigs superfused tracheal strips. Journal of Pharmacology & Experimental Therapeutics 264(2): 717-725

Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty by intracoronary application of dipyridamole: impact on hemodynamic function and left ventricular performance. Journal of the American College of Cardiology 28(5): 1119-1126

Pharmacologic options for the overactive bladder. Urology. 51(2a Suppl.): 43-47,.

Pharmacologic preconditioning with monophosphoryl lipid A is abolished by 5-hydroxydecanoate, a specific inhibitor of the K(ATP) channel. Journal of Cardiovascular Pharmacology 32(3): 337-342

Pharmacologic principles of pyelonephritis treatment. Distribution, efficiency and renal toxicity of antibiotics. M S (Medecine Sciences) 13(8-9): 942-951

Pharmacologic profile and efficacy of venlafaxine. International Clinical Psychopharmacology 10 Suppl 2: 5-13

Pharmacologic profile of CGS 24128, a potent, long-acting inhibitor of neutral endopeptidase 24.11. Journal of Cardiovascular Pharmacology 23(3): 358-364

Pharmacologic profile of TA-606, a novel angiotensin II-receptor antagonist in the rat. Journal of Cardiovascular Pharmacology 31(4): 568-575

Pharmacologic profile of crataegus extract compared to epinephrine, amrinone, milrinone and digoxin in isolated guinea pig hearts. Arzneimittel-Forschung 45(12): 1261-1265

Pharmacologic profile of endothelin-A/B antagonist, (Thr-18,gamma-methylLeu-19) endothelin-1. Journal of Cardiovascular Pharmacology 22(SUPPL. 8): S107-S110

Pharmacologic profile of ropinirole: a nonergoline dopamine agonist. Neurology 49(1 Suppl 1): S58-S62

Pharmacologic profile of survivors of acute myocardial infarction at United States academic hospitals. American Heart Journal. 131(5): 872-878

Pharmacologic profiles of KRH-594, a novel nonpeptide angiotensin II-receptor antagonist. Journal of Cardiovascular Pharmacology 30(5): 607-615

Pharmacologic properties of Daflon 500 mg. Angiology 45(6 Pt 2): 524-530

Pharmacologic properties of KT2-962 (6-isopropyl-3-(4-(p-chlorobenzenesulfonylamino)butyl)azulene-1-sulfonic acid sodium salt): A new TXA-2/prostaglandin endoperoxide receptor antagonist. Journal of Cardiovascular Pharmacology 21(3): 441-447

Pharmacologic properties of a novel Ca2+ entry blocker, AJ-2615, in vitro. Journal of Cardiovascular Pharmacology 22(6): 804-809

Pharmacologic prophylaxis of supraventricular tachyarrhythmias after coronary artery bypass. Pharmacotherapy. 16(4): 615-618

Pharmacologic quantitation. Indian Journal of Experimental Biology 34(7): 615-633

Pharmacologic reduction of factor XIII activity and fibrinogenemia in patients with peripheral arterial occlusive disease. Current Therapeutic Research. 59(6): 389-394, E

Pharmacologic reduction of pretransplantation pulmonary vascular resistance predicts outcome after pediatric heart transplantation. Journal of Heart and Lung Transplantation 12(6 Pt 1): 965-72; Discussion 972-3

Pharmacologic restoration of suppressed temperature rhythms in rats by melatonin, melatonin receptor agonist, S20242, or 8-OH-DPAT. European Journal Of Pharmacology. 347(1): 57-66, Il 17

Pharmacologic shifting of a balance between protein refolding and degradation mediated by Hsp90. Proceedings Of The National Academy Of Sciences Of The United States Of America. 93(25): 14536-14541

Pharmacologic specificity of antidepressive activity by monoaminergic neural transplants. Psychopharmacology. 118(1): 10-18

Pharmacologic strategies for the treatment of meningeal malignancy. Investigational New Drugs. 14(1): 69-85

Pharmacologic stress dual-isotope myocardial perfusion single-photon emission computed tomography. American Heart Journal. 128(6 Part 1): 1067-1076

Pharmacologic stress-induced regional myocardial blood flow heterogeneity and left ventricular wall thickening abnormality: Comparison of intravenous adenosine with dipyridamole in a model of critical coronary stenosis. American Heart Journal 133(1): 78-86

Pharmacologic studies of one of Kanno-gan formulations. Natural Medicines 51(2): 108-124

Pharmacologic studies on the mechanism of melatonin-induced vasorelaxation in rat aorta. Journal Of Pineal Research. : 133-138

Pharmacologic study of 3-hour 135 mg M-2 paclitaxel in platinum pretreated patients with advanced ovarian cancer. Pharmacological Research 38(3): 231-236

Pharmacologic study of basophil histamine release induced by monocyte chemotactic protein-1 with kinase inhibitors. International Archives of Allergy and Immunology 111(1): 18-22

Pharmacologic support with high-energy phosphate preservation in the postischemic neonatal heart. Annals Of Thoracic Surgery. 59(6): 1435-1439

Pharmacologic therapy for prostatism. Mayo Clinic Proceedings 73(6): 590-596

Pharmacologic therapy of atrial flutter. Journal Of Cardiovascular Electrophysiology. 7(10): 1008-1012

Pharmacologic therapy of bone tissue destruction due to haematologic malignancies and bone metastases. Acta Haematologica Polonica 25(2): 91-98

Pharmacologic therapy of rheumatic diseases. Medicina (Ribeirao Preto) 30(4): 522-531, Oct -Dec

Pharmacologic treatment and/or balneotherapy of chronic venous insufficiency. Gazzetta Medica Italiana Archivio per le Scienze Mediche 155(4): 179-185

Pharmacologic treatment of atherosclerosis: Beyond lipid-lowering therapy. International Journal of Cardiology 62(SUPPL. 2): S17-S22

Pharmacologic treatment of body dysmorphic disorder. Psychopharmacology Bulletin 32(4): 597-605

Pharmacologic treatment of cognition in Alzheimer's dementia. Neurology 51(1 Suppl 1): S36-44; Discussion S65-7

Pharmacologic treatment of congestive heart failure. Clinical Cardiology. : 271-277

Pharmacologic treatment of desmoid tumors in familial adenomatous polyposis: results of an in vitro study. Surgery 115(4): 473-479

Pharmacologic treatment of emotional lability. Clinical Neuropharmacology 19(6): 532-535

Pharmacologic treatment of geriatric depression: key issues in interpreting the evidence. Journal of the American Geriatrics Society 46(1): 106-110

Pharmacologic treatment of noncognitive symptoms of dementia. Acta Neurologica Scandinavica. 93(suppl. 165): 101-104

Pharmacologic treatment of panic disorder. Current Therapeutic Research. 54(6): 820-824

Pharmacologic treatment of psychiatric disease in pregnancy and lactation: Fetal and neonatal effects. Obstetrics and Gynecology 87(5 PART 1): 789-794

Pharmacologic treatment of schizoaffective disorder. Psychopharmacology. 114(4): 529-538

Pharmacologic treatment of sleep-disordered breathing. American Journal of Respiratory and Critical Care Medicine 158(3): 691-699

Pharmacologic treatment of thalassemia intermedia with hydroxyurea. Journal of Pediatrics 125(3): 490-492

Pharmacologic treatment options for non-insulin-dependent diabetes mellitus. Mayo Clinic Proceedings 71(8): 763-768

Pharmacologic treatment strategies for the depressed, poorly responsive patient. Southern Medical Journal 85(11): 1122-6, 1130

Pharmacologic treatments for temporomandibular disorders. Oral Surgery Oral Medicine Oral Pathology Oral Radiology & Endodontics. 83(1): 134-142

Pharmacologic validation of human tumor clonogenic assays based on pleiotropic drug resistance: implications for individualized chemotherapy and new drug screening programs. International Journal of Cell Cloning 10(6): 359-368

Pharmacologic variables associated with the development of neurologic toxicity in patients treated with suramin. Journal of Clinical Oncology 13(9): 2223-2229

Pharmacologic, toxicologic, and marrow transplantation studies in dogs given succinyl acetone. Transplantation 54(5): 813-820

Pharmacologic-guided trial of sequential methotrexate and thioguanine in children with advanced malignancies. Journal of Clinical Oncology 12(9): 1955-1962

Pharmacological Activities of Gardenia jovis-tonantis. International Journal of Pharmacognosy 33(3): 250-252

Pharmacological Activity of Oxalis corniculata. International Journal of Pharmacognosy 33(3): 247-249

Pharmacological analysis in rat of the role of the ATP-sensitive potassium channel as a potential target for antifibrillatory intervention in acute myocardial ischaemia. Journal of Cardiovascular Pharmacology 26(2): 280-288

Pharmacological Analysis of the Inhibitory Effects of KRN2391 on Endothelin-1-induced Contraction in Isolated Large Coronary Artery of the Pig. General Pharmacology. 25(5): 935-939

Pharmacological analysis of the scratching produced by dopamine D2 agonists in squirrel monkeys. Journal of Pharmacology and Experimental Therapeutics 273(1): 138-145

Pharmacological characterization of dynorphin A (1-17)-induced effects on spinal cord-evoked potentials. Journal of Pharmacology and Experimental Therapeutics 270(2): 534-539

Pharmacological Characterization of Enantiomers of 8-Thiomethyl-2-(di-n-propylamino)tetralin, Potent and Selective 5-HT-1A Receptor Agonists. Drug Development Research 34(1): 66-85

Pharmacological coupling and functional role for the muscarinic receptor subtypes in isolated cells from the circular smooth muscle of the rabbit cecum. Journal of Pharmacology and Experimental Therapeutics 271(1): 149-155

Pharmacological Heterogeneity of the Cloned and Native Human Dopamine Transporter: Disassociation of (3H)WIN 35,428 and (3H)GBR 12,935 Binding. Molecular Pharmacology 45(1): 125-135

Pharmacological modulation of cardiac fibroblast function. Herz 20(2): 127-134

Pharmacological modulation of platelet-derived growth factor (B) mRNA expression in alveolar macrophages and adherent monocytes. Pulmonary Pharmacology 7(6): 383-391

Pharmacological properties of KT3-671, a novel nonpeptide angiotensin II receptor antagonist. Journal of Cardiovascular Pharmacology 25(1): 22-29

Pharmacological research on antiasthmatic liquid for oral administration. Zhongguo Zhong Yao Za Zhi 20(5): 305-6, Inside Cover

Pharmacological Studies of Oxycodone Hydrochloride 1. Antinociceptive Effect and General Pharmacology. Oyo Yakuri 49(3): 257-273

Pharmacological Studies of Oxycodone Hydrochloride 2. Polygraphic Analysis in Conscious Dogs. Oyo Yakuri 49(3): 275-286

Pharmacological studies with two new ergoline derivatives, the potential antipsychotics LEK-8829 and LEK-8841. Journal of Pharmacology and Experimental Therapeutics 271(1): 343-352

Pharmacological Study on Ginger Processing: I. Antiallergic Activity and Cardiotonic Action of Gingerols and Shogaols. Natural Medicines 49(1): 76-83

Pharmacological action mechanism(s) of vasodilator effect of calcitonin gene-related peptide in rat basilar arteries. Korean Journal of Pharmacology 32(1): 39-49

Pharmacological action of (levo)-(2S,3aR,7aS)-1-((S)-N-((S)-1-carbonyl-3-phenylpropyl)alanyl)hexahydro-2-indolinecarboxylic acid (trandolaprilat) in isolated smooth muscle preparations. General Pharmacology 24(3): 585-590

Pharmacological action of Australian animal venoms. Clinical & Experimental Pharmacology & Physiology. 24(1): 10-17

Pharmacological action of a novel angiotensin converting enzyme (ACE) inhibitor, RU44570, namely levo (2S,3aR,7aS)-1-((S)-N-((S)-1-ethoxycarbonyl-3-phenylpropyl)alanyl)hexahydro-2-indolinecarboxylic acid: In vivo ACE inhibiting effect and antihypertensive effect in various hypertensive models of rats. Pharmacometrics 45(1): 15-25

Pharmacological action of the heptapeptide GFSKLYFamide in the muscle of the sea cucumber Holothuria glaberrima (Echinodermata). Comparative Biochemistry and Physiology C Pharmacology Toxicology and Endocrinology 110(2): 171-176

Pharmacological action of zotepine and other antipsychotics on central 5-hydroxytryptamine receptor subtypes. Arzneimittel-Forschung 44(2): 113-118

Pharmacological actions of "kyushin," a drug containing toad venom (3): Effects on experimentally induced arrhythmia. American Journal of Chinese Medicine 21(2): 139-149

Pharmacological actions of "kyushin," a drug containing toad venom: cardiotonic and arrhythmogenic effects, and excitatory effect on respiration. American Journal of Chinese Medicine 20(3-4): 245-256

Pharmacological actions of New Woohwangchungsimwon Pill on cardiovascular system. Yakhak Hoeji 41(6): 802-816, Dec

Pharmacological actions of New Woohwangchungsimwon Pill on cerebral ischemia and central nervous system. Yakhak Hoeji 41(6): 817-828, Dec

Pharmacological actions of SDZ 218-135, a novel positive inotropic agent. Cardiovascular Drugs & Therapy. 8(2): 235-244

Pharmacological actions of essential (zinc, copper) and toxic metal ions (lead, mercury) on neurons and neuronal synapses of the snail, Helix pomatia L. Neurotoxicology 19(4-5): 565-569

Pharmacological actions of hyphae body of Auricularia auricula (L. ex Hook) Underw and its alcoholic extract. Zhongguo Zhong Yao Za Zhi 19(7): 430-2, 448

Pharmacological actions of melatonin in oxygen radical pathophysiology. Life Sciences. 60(25): 2255-2271

Pharmacological actions of the atypical antipsychotic drug clozapine: A review. Synapse (New York) 24(4): 349-394

Pharmacological actions of the coenzymes NAD(H) and NADP(H) on the rat anococcygeus muscle. Clinical and Experimental Pharmacology and Physiology 21(1): 9-20

Pharmacological actions of the selective and non-selective beta-adrenoceptor antagonists celiprolol, bisoprolol and propranolol on human bronchi. British Journal of Pharmacology 113(3): 1043-1049

Pharmacological activation changes stiffness of cultured human airway smooth muscle cells . American Journal of Physiology 271(5 Pt 1): C1660-8

Pharmacological activities and the constituents of the leaves of Hedera rhombea Bean (II): On the constituents of the leaves. Archives of Pharmacal Research (Seoul) 16(4): 331-335

Pharmacological activities of bisbenzylisoquinoline alkaloids: A review. Journal of Medicinal & Aromatic Plant Sciences 19(1): 32-92

Pharmacological activities of chlorpromazine involved in the inhibition of tumour necrosis factor production in vivo in mice. Immunology 79(2): 217-219

Pharmacological activities of heparin chains: should our past knowledge be revised?. Haemostasis 26 Suppl 2: 2-9

Pharmacological activities of khellactones, compounds isolated from Peucedanum japonicum THUNB. and Peucedanum praeruptorium DUNN. Methods and Findings in Experimental and Clinical Pharmacology 20(4): 343-351

Pharmacological activities of some synthetic peptides related to dermorphin. Indian Journal of Pharmacology 29(2): 92-98

Pharmacological activities of trimetoquinol and 1-benzyl halogen-substituted analogues on rat beta-adrenoceptor subtypes. European Journal of Pharmacology 305(1-3): 63-71

Pharmacological activity and local and systemic tolerance of topically applied iloprost. Arzneimittel-Forschung 43(4): 450-454

Pharmacological activity and membrane interactions of antiarrhythmics: 4D-QSAR/QSPR analysis. Pharmaceutical Research (New York) 15(2): 303-311

Pharmacological activity and safety profile of P10358, a novel, orally active acetylcholinesterase inhibitor for Alzheimer's disease. Journal of Pharmacology and Experimental Therapeutics 280(2): 710-720

Pharmacological activity of Guarana (Paullinia cupana Mart.) in laboratory animals. Journal of Ethnopharmacology 55(3): 223-229

Pharmacological activity of PF-904 in guinea pig in vivo, and on human bronchus and neutrophils in vitro. European Journal of Pharmacology 333(1): 69-78

Pharmacological activity of Prunella vulgaris in relation with epidemic differentiation. Acta Botanica Gallica 144(4): 485-488

Pharmacological activity of carnosine. Eksperimental'naya i Klinicheskaya Farmakologiya 58(2): 66-74

Pharmacological activity of chemically modified subfragment from human serum IgG. XI. Increment of tumor necrosis factor (TNF) activity in mouse sera by carboxamide-methylated light chain. Biological & Pharmaceutical Bulletin 17(2): 197-200

Pharmacological activity of chemically modified subfragment from human serum IgG. XIV. Inhibitory effect of carboxamide-methylated light chain (G1L) on tyrosine phosphorylation and tumor necrosis factor-alpha production from murine macrophages stimulated by lipopolysaccharide. Biological & Pharmaceutical Bulletin 18(10): 1377-1381

Pharmacological activity of levo-discretamine, a novel vascular alpha-adrenoceptor and 5-hydroxytryptamine receptor antagonist, isolated from Fissistigma glaucescens. British Journal of Pharmacology 110(2): 882-888

Pharmacological activity of pyrrole derivatives. Khimiko-Farmatsevticheskii Zhurnal 26(6): 26-29

Pharmacological activity of tablets containing recombinant human granulocyte colony-stimulating factor (rhG-CSF) in rats. International Journal of Pharmaceutics (Amsterdam) 101(1-2): 89-96

Pharmacological activity of the C-terminal and N-terminal domains of secretory leukoprotease inhibitor in vitro. British Journal Of Pharmacology. 115(6): 883-888

Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. European Journal Of Pharmacology. 231(2): 313-314

Pharmacological activity of the dry extract from the above-ground part of Desmodium canadense (L.) DC. in the toxic kidneys disorders. Rastitel'nye Resursy 32(3): 113-118

Pharmacological activity of the dry extract from the leaves of Arctostaphylos uva-ursi L. in experimental nephropyelitis. Rastitel'nye Resursy 32(3): 118-123

Pharmacological activity of the fraction isolated from virgin olive oil containing the sterols and triterpenic alcohols. Grasas y Aceites 48(2): 93-95, March-April

Pharmacological activity of the interdomain segment between metalloproteinase and disintegrin domains. Toxicon. 35(4): 529-535

Pharmacological activity of the new calcium antagonist, lacidipine, on isolated preparations. General Pharmacology. 27(7): 1255-1259

Pharmacological activity of the second generation leukotriene B4 receptor antagonist, SC-53228: effects on acute colonic inflammation and hepatic function in rodents. Inflammation 19(5): 503-515

Pharmacological activity of transdermal therapeutic systems containing nitroglycerin and nitrosorbide. Farmatsiya (Moscow) 40(5): 51-54

Pharmacological agents for stress testing in the diagnosis of coronary artery disease. European Heart Journal 16 Suppl M: 1-2

Pharmacological alteration of sleep and dreams: A clinical framework for utilizing the electrophysiological and sleep stage effects of psychoactive medications. Human Psychopharmacology 11(3): 217-223

Pharmacological analyses of endo-6-methoxy-8-methyl-8-azabicyclo(3.2.1)oct-3-yl-2,3-dihydro-2-oxo-1H-benzimidazole-1-carboxylate hydrochloride (DAU 6285) at the 5-hydroxytryptamine-4 receptor in the tunica muscularis mucosae of rat esophagus and ileum of guinea pig: Role of endogenous 5-hydroxytryptamine. Journal of Pharmacology and Experimental Therapeutics 264(2): 654-661

Pharmacological analysis of 4-Carboxyphenylglycine derivatives: Comparison of effects on the mGluR1-alpha and mGluR5a subtypes. Neuropharmacology 34(8): 887-894

Pharmacological analysis of behavior elicited by electrical stimulation of the ventromedial hypothalamus in rabbits and modulated by pentagastrin. Byulleten' Eksperimental'noi Biologii i Meditsiny 116(8): 178-181

Pharmacological analysis of carboxyphenylglycines at metabotropic glutamate receptors. European Journal of Pharmacology Molecular Pharmacology Section 17(1): 9-15

Pharmacological analysis of cerebellar contributions to the timing and expression of conditioned eyelid responses. Neuropharmacology. 37(4-5): 471-480, Il-

Pharmacological analysis of cholinergic system in Daphnia magna. Zhurnal Evolyutsionnoi Biokhimii i Fiziologii 30(3): 386-391

Pharmacological analysis of diisopropyl fluorophosphate: Effects on core temperature, heart rate, and motor activity in the unrestrained rat. Pharmacology Biochemistry and Behavior 55(2): 185-194

Pharmacological analysis of dopamine stimulation of (35S)-GTP-gamma-S binding via human D-2short and D-2long dopamine receptors expressed in recombinant cells. British Journal of Pharmacology 118(6): 1544-1550

Pharmacological analysis of ecto-ATPase inhibition: Evidence for combined enzyme inhibition and receptor antagonism in P-2X-purinoceptor ligands. British Journal of Pharmacology 113(4): 1432-1438

Pharmacological analysis of free radicals mechanism of intoxication memory disorders. Patologicheskaya Fiziologiya i Eksperimental'naya Terapiya 0(1): 8-10

Pharmacological analysis of heartbeat in Drosophila. Journal of Neurobiology 28(3): 269-280

Pharmacological analysis of mast cell mediator and neurotransmitter receptors coupled to adenylate cyclase and phospholipase C on immunocytochemically-defined human conjunctival epithelial cells. Journal of Ocular Pharmacology and Therapeutics 13(4): 321-336

Pharmacological analysis of monoamine synthesis and catabolism in the scallop, Placopecten magellanicus. General Pharmacology. 31(1): 67-73, Y

Pharmacological analysis of neutrophil chemotactic factor production by leucocytes and roles of PAF in allergic inflammation in rats. British Journal Of Pharmacology. 111(1): 123-130

Pharmacological analysis of receptors for bombesin-related peptides on guinea pig gallbladder smooth muscle. Regulatory Peptides. 52(3): 173-180

Pharmacological analysis of receptors involved in the late, tachykininergic contractile response to electrical transmural stimulation in isolated rabbit iris sphincter muscle. Japanese Journal of Pharmacology 62(3): 257-261

Pharmacological analysis of responses to ATP in the isolated and perfused canine coronary artery. European Journal Of Pharmacology. 334(2-3): 173-180

Pharmacological analysis of sinus rhythm. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 102(4): 257-270

Pharmacological analysis of the CCK-B/gastrin receptors mediating pentagastrin-stimulated gastric acid secretion in the isolated stomach of the immature rat. British Journal Of Pharmacology. 119(7): 1401-1410

Pharmacological analysis of the cardiac effects of 5-HT and some 5-HT receptor agonists in the pithed rat. Fundamental & Clinical Pharmacology. 6(6): 237-245

Pharmacological analysis of the inflammatory exudate-induced histamine production in bone marrow cells. Immunopharmacology. 36(1): 87-94

Pharmacological analysis of the interaction between purinoceptor agonists and antagonists in the guinea-pig taenia caecum. British Journal Of Pharmacology. 115(4): 549-556

Pharmacological analysis of the local and reflex responses to bradykinin on rat urinary bladder motility in vivo. British Journal Of Pharmacology. 114(3): 708-714

Pharmacological analysis of the methanolic extract and sorocein A, a new Diels-Alder compound isolated from the roots of Sorocea bonplandii Bailon in the isolated rat uterus and guinea pig ileum. General Pharmacology. 24(4): 983-989

Pharmacological analysis of the mode of interaction of McN-A-343 at atrial muscarinic M2 receptors. European Journal Of Pharmacology. 339(2-3): 153-156,. 27

Pharmacological analysis of the native and cloned rat D-2 receptor. Molecular Neuropharmacology 3(4): 207-213

Pharmacological analysis of the noradrenergic control of central sympathetic and somatic reflexes controlling the lower urinary tract in the anesthetized cat. Journal of Pharmacology and Experimental Therapeutics 274(2): 820-825

Pharmacological analysis of the rate-decreasing effects of mu and kappa opioids in pigeons. Psychopharmacology 113(3-4): 457-462

Pharmacological analysis of the role of the GABA and opioidergic systems in the development of brain edema. Byulleten' Eksperimental'noi Biologii i Meditsiny 114(8): 163-165

Pharmacological analysis of the tachykinin receptors that mediate activation of nonadrenergic, noncholinergic relaxant nerves that innervate guinea pig trachealis. Journal of Pharmacology and Experimental Therapeutics 284(1): 370-377

Pharmacological analysis of the vasodepressor effect of KRN2391 in pithed rats. General Pharmacology. 24(6): 1379-1381

Pharmacological analysis of voltage-dependent potassium currents in cultured skeletal myocytes of the frog Rana temporaria. General Physiology and Biophysics 14(6): 525-534

Pharmacological and behavioral evaluation of alkylated anandamide analogs. Life Sciences. 56(23-24): 2041-2048

Pharmacological and biochemical analysis of FPL 67156, a novel, selective inhibitor of ecto-ATPase. British Journal Of Pharmacology. 114(2): 475-481

Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proceedings of the National Academy of Sciences of the United States of America 91(25): 12013-7

Pharmacological and biochemical determinants of the antitumour activity of the indoloquinone EO9. Biochemical Pharmacology. 55(3): 253-260,. 1

Pharmacological and biochemical evidence for the regulation of osteocalcin secretion by potassium channels in human osteoblast-like MG-63 cells. Journal of Bone and Mineral Research 12(12): 1984-1992

Pharmacological and biochemical profiles of unique neurotensin 8-13 analogs exhibiting species selectivity, stereoselectivity, and superagonism. Journal of Biological Chemistry 270(31): 18359-18366

Pharmacological and chemical screening of Byrsonima crassifolia, a medicinal tree from Mexico. Part I. Journal of Ethnopharmacology 39(2): 141-158

Pharmacological and clinical implications of MAO-B inhibitors. General Pharmacology. 25(8): 1527-1539

Pharmacological and clinical modification of prokinetic agents. Leber Magen Darm 26(4): 193-198

Pharmacological and clinical study of analgesic freeze spray. Acta Academiae Medicinae Shanghai 23(4): 267-270

Pharmacological and developmental evidence that the potassium-induced stimulation of deoxyglucose uptake in astrocytes is a metabolic manifestation of increased Na(+)-K(+)-ATPase activity. Developmental Neuroscience 18(5-6): 353-359

Pharmacological and electrographic properties of epileptiform activity induced by elevated K+ and lowered Ca2+ and Mg2+ concentration in rat hippocampal slices. Experimental Brain Research 96(2): 230-240

Pharmacological and electrophysiological characterization of a postsynaptic muscarinic receptor in the central nervous system of the cockroach. Journal of Experimental Biology 181(0): 257-278

Pharmacological and functional characterization of D2, D3 and D4 dopamine receptors in fibroblast and dopaminergic cell lines. Journal of Pharmacology and Experimental Therapeutics 268(1): 495-502

Pharmacological and functional characterization of bradykinin receptors in canine cultured tracheal epithelial cells. British Journal Of Pharmacology. 119(2): 439-445

Pharmacological and functional characterization of human mineralocorticoid and glucocorticoid receptor ligands. European Journal Of Pharmacology Molecular Pharmacology Section. 13(2): 145-154

Pharmacological and functional characterization of muscarinic receptors in the frog pars intermedia. Endocrinology 139(8): 3525-3533

Pharmacological and functional properties of voltage-independent Ca2+ channels. Cell Calcium 19(4): 269-279

Pharmacological and genetic evidence for a role of rootlet and phycoplast microtubules in the positioning and assembly of cleavage furrows in Chlamydomonas reinhardtii. Cell Motility and the Cytoskeleton 40(2): 193-207

Pharmacological and histochemical evidence for P2X receptors in human umbilical vessels. European Journal Of Pharmacology. 353(1): 59-65, Y 17

Pharmacological and immunocytochemical characterization of metabotropic glutamate receptors in cultured Purkinje cells. Journal of Neuroscience 12(11): 4253-4263

Pharmacological and immunocytochemical characterization of subtypes of alpha-1 adrenoceptors in dog aorta. Journal of Pharmacology and Experimental Therapeutics 285(2): 894-901

Pharmacological and immunohistochemical evidence for a functional nitric oxide synthase system in rat peritoneal eosinophils. Proceedings Of The National Academy Of Sciences Of The United States Of America. 94(25): 14111-14114,. 9

Pharmacological and immunohistochemical evidence for serotonergic modulation of cholinergic nucleus basalis neurons. European Journal Of Neuroscience. 5(5): 541-547

Pharmacological and immunological characterization of N-methyl-D-aspartate receptors in human NT2-N neurons. Journal of Pharmacology and Experimental Therapeutics 276(2): 819-828

Pharmacological and molecular actions of the bradykinin B-2 receptor antagonist, Hoe 140, in the rat uterus. European Journal Of Pharmacology. 235(2-3): 183-188

Pharmacological and molecular characterisation of beta-adrenoceptors in adult rat diaphragm muscle. Respiration Physiology 112(1): 1-12

Pharmacological and molecular characterization of intrinsic and acquired doxorubicin resistance in murine tumor cell lines. Journal Of Cancer Research & Clinical Oncology. 119(9): 527-532

Pharmacological and molecular characterization of muscarinic receptors in cat esophageal smooth muscle. Journal of Pharmacology and Experimental Therapeutics 285(2): 853-861

Pharmacological and molecular characterization of the neurotensin receptor expressed in Sf9 cells. Biochemical Pharmacology. 51(9): 1243-1246

Pharmacological and molecular discrimination of brain I-2-imidazoline receptor subtypes. Naunyn-Schmiedeberg'S Archives Of Pharmacology. 354(6): 709-716

Pharmacological and molecular evidence for the expression of the two steroid 5-alpha-reductase isozymes in normal and hyperplastic human prostatic cells in culture. Prostate 32(3): 155-163

Pharmacological and morphological effects of in vitro transluminal balloon angioplasty on normal and vasospastic canine basilar arteries. Journal of Neurosurgery 83(3): 522-530

Pharmacological and neuroanatomical evidence for the involvement of the anterior pretectal nucleus in the antinociception induced by stimulation of the dorsal raphe nucleus in rats. Pain. 74(2-3): 171-179,.

Pharmacological and non-pharmacological smoking motives: A replication and extension. Addiction 89(3): 321-330

Pharmacological and pathological studies on Taiwan folk medicine (IX): The hepatoprotective effect of the methanolic extract from echinops grijisii. American Journal of Chinese Medicine 21(1): 33-44

Pharmacological and pathological studies on hepatic protective crude drugs from Taiwan (V): The effects of Bombax malabarica and Scutellaria rivularis. American Journal of Chinese Medicine 20(3-4): 257-264

Pharmacological and pathophysiological effects of periadventitial stripping on immediate and subacute postoperative vasoconstriction in Guinea pigs. Neurosurgical Review. 20(1): 45-50

Pharmacological and pharmacokinetic characteristics of YM435, a novel dopamine DA-1-receptor agonist, in anaesthetized dogs. Journal Of Pharmacy & Pharmacology. 49(9): 892-896

Pharmacological and pharmacokinetic evaluation of EXP3312, an orally-active non-peptide angiotensin II-receptor antagonist. Journal Of Pharmacy & Pharmacology. 48(5): 492-497

Pharmacological and physicochemical properties of collagen breakdown-products. Acta Neurobiologiae Experimentalis 52(4): 223-232

Pharmacological and regional characterization of tritiated LY278584 binding sites in human brain. Journal of Neurochemistry 60(2): 730-737

Pharmacological and second messenger signalling selectivities of cloned P2Y receptors. Journal Of Autonomic Pharmacology. 16(6): 319-323

Pharmacological and structural integrity of muscarinic M-2 acetylcholine receptors produced in Sf9 insect cells. European Journal Of Pharmacology. 333(2-3): 269-278

Pharmacological and toxicological aspects of new imidazoacridinone antitumor agents. Cancer Research 56(9): 2094-2104

Pharmacological and toxicological effects of chronic porcine growth hormone administration in dogs. Toxicologic Pathology 26(2): 185-200

Pharmacological and toxicological properties of the new Sumetrolim inj. Magyar Allatorvosok Lapja 47(10): 555-561

Pharmacological and toxicological studies of the new angiotensin converting enzyme inhibitor moexipril hydrochloride. Arzneimittel-Forschung 47(2): 132-144

Pharmacological antagonism of alpha-adrenergic agonist induced increases in canine intraurethral pressure in vivo. Drug Development Research 34(3): 267-275

Pharmacological antagonism of lipoprivic feeding induced by sodium mercaptoacetate. European Journal Of Pharmacology. 276(3): 285-289

Pharmacological antagonism of the actions of group II and III mGluR agonists in the lateral perforant path of rat hippocampal slices. British Journal Of Pharmacology. 117(7): 1457-1462

Pharmacological approach to control American foulbrood of honeybees. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 110(4): 183-193

Pharmacological approach to the H-3-histaminic receptor by arterial and bronchiolar perfusion system. Annales Pharmaceutiques Francaises 54(5): 217-222

Pharmacological approaches in the treatment of primary hyperoxaluria. Journal of Nephrology 11 Suppl 1: 32-35

Pharmacological approaches other than opioids in chronic non-cancer pain management. Acta Anaesthesiologica Scandinavica. 41(1 Part 2): 187-190

Pharmacological approaches to counter the toxicity of dopa. Amino Acids (vienna). 14(1-3): 189-196

Pharmacological aspects of acid secretion. Digestive Diseases & Sciences. 40(2 Suppl.): 3s-23s

Pharmacological aspects of arthritis induced by a muramyl dipeptide analogue in rats. European Journal Of Pharmacology Environmental Toxicology & Pharmacology Section. 1(2-3): 147-153

Pharmacological aspects of calcium channel blockers. Cardiovascular Drugs & Therapy. 10(suppl. 3): 869-872

Pharmacological aspects of mouse hind-paw oedema induced by Lachesis muta rhombeata venom. Toxicon. 36(5): 771-780,

Pharmacological aspects of obesity treatment: towards the 21st century. International Journal of Obesity and Related Metabolic Disorders 19 Suppl 3: S51-S55

Pharmacological aspects of pentoxifylline with emphasis on its inhibitory actions on hepatic fibrogenesis. General Pharmacology. 29(2): 181-196

Pharmacological aspects of withdrawal from certain benzodiazepines. Polish Journal of Pharmacology 49(2-3): 89-95

Pharmacological assay of Petiveria alliacea. II. Oral anti-inflammatory activity and gastrotoxicity of a hydroalcoholic root extract. Fitoterapia 66(3): 195-202

Pharmacological assessment of spantide II analogues. European Journal Of Pharmacology. 260(2-3): 121-128

Pharmacological attempts to improve the bioavailability of oral etoposide. Cancer Chemotherapy & Pharmacology. 37(1-2): 125-133

Pharmacological background of puerperal psychosis. Singapore Journal of Obstetrics & Gynaecology 26(3): 171-175

Pharmacological backgrounds of the drug treatment of hypertension in the elderly. Blood Pressure. Supplement 3: 15-20

Pharmacological basis for functional selectivity of partial muscarinic receptor agonists. European Journal Of Pharmacology. 297(3): 283-291

Pharmacological basis for hepatic drug metabolism in sheep. Veterinary Research 27(4-5): 363-372

Pharmacological basis for the surveillance of drug residues in animal origin food. Veterinaria - Mexico 26(3): 175-182

Pharmacological basis for the treatment of bovine mastitis. Veterinaria - Mexico 27(1): 63-82

Pharmacological basis of contractile effects of peptidoleukotrienes on rabbit colonic muscularis mucosae. American Journal of Physiology 264(1 Pt 1): G81-G85

Pharmacological basis of postoperative pain therapy. Epidural opioid administration. Anaesthesist 46(SUPPL 3): S154-S158

Pharmacological biocompatibility between intravesical preparations of BCG and interferon-alpha 2B. Journal Of Urology. 158(6): 2311-2315,.

Pharmacological bioequivalence of four oxytetracycline commercial preparations. Veterinaria - Mexico 26(3): 183-187

Pharmacological block of the electrogenic sodium pump disrupts rhythmic bursting induced by strychnine and bicuculline in the neonatal rat spinal cord. Journal of Neurophysiology 77(1): 17-23

Pharmacological blockade of protein glycosylation in diabetes mellitus with sulfonyl urea derivatives and biguanides. Eksperimental'naya i Klinicheskaya Farmakologiya 59(5): 40-42

Pharmacological but not physiological modulation of cortical acetylcholine release by cholinergic mechanisms in the nucleus basalis magnocellularis. Canadian Journal Of Physiology & Pharmacology. 72(8): 893-898

Pharmacological cardiac stress: when and how?. Nuclear Medicine Communications 15(8): 578-585

Pharmacological characterisation and autoradiographic localisation of a putative dopamine D3 receptor in the rat kidney. European Journal Of Pharmacology. 338(1): 89-95,. 29

Pharmacological characterisation of (35S)-GTP-gamma-S binding to Chinese hamster ovary cell membranes stably expressing cloned human 5-HT-1D receptor subtypes. Journal of Receptor and Signal Transduction Research 15(1-4): 199-211

Pharmacological characterisation of Ca-2+ channels of the L-type in human peripheral blood lymphocytes. European Journal Of Pharmacology. 301(1-3): 189-194

Pharmacological characterisation of NK-1 receptor antagonist, (D-Trp-7)sendide, on behaviour elicited by substance P in the mouse. Naunyn Schmiedeberg's Archives of Pharmacology 350(4): 387-392

Pharmacological characterisation of a new model of antigen-induced pulmonary late-phase reaction in the conscious guinea pig which uses additional polymyxin B inhalation. Journal Of Lipid Mediators & Cell Signalling. 15(1): 17-28

Pharmacological characterisation of excitatory synaptic transmission in the cat red nucleus in vivo. Brain Research. 649(1-2): 43-52

Pharmacological characterisation of human cerebral cortex somatostatin SRIF-1 and SRIF-2 receptors. Naunyn-Schmiedeberg'S Archives Of Pharmacology. 355(2): 161-167

Pharmacological characterisation of metabotropic glutamatergic and purinergic receptors linked to Ca2+ signalling in hippocampal astrocytes. Neuropharmacology. 37(2): 169-178

Pharmacological characterisation of neurokinin receptors mediating anion secretion in rat descending colon mucosa. Naunyn-Schmiedeberg'S Archives Of Pharmacology. 348(2): 172-177

Pharmacological characterisation of oxytocin binding sites in the ovine pineal gland. Regulatory Peptides. 70(1): 23-27

Pharmacological characterisation of the D2 dopamine receptor expressed in the yeast Schizosaccharomyces pombe. Biochemical Pharmacology. 56(5): 577-582,. 1

Pharmacological characterisation of the calcium channels coupled to the plateau phase of KCl-induced intracellular free Ca-2+ elevation in chicken and rat synaptosomes. Neuropharmacology. 32(11): 1195-1202

Pharmacological characterisation of the histamine H3 receptor in the rat hippocampus. Brain Research. 788(1-2): 179-186, Ch 30

Pharmacological characterisation of the recombinant human CRF binding protein using a simple assay. Journal Of Neuroscience Methods. 80(1): 99-105, Ch 12

Pharmacological characterisation of voltage-sensitive calcium channels and neurotransmitter release from mouse cerebellar granule cells in culture. Journal Of Neuroscience Research. 48(1): 43-52

Pharmacological characteristics of DQ-2511 as a prokinetic agent. Archives Internationales de Pharmacodynamie et de Therapie 330(3): 332-344

Pharmacological characteristics of GABA-A responses in postnatal suprachiasmatic neurons in culture. Neuroscience Letters. 160(1): 45-48

Pharmacological characteristics of Sho-seiryu-to, an antiallergic Kampo medicine without effects on histamine H1 receptors and muscarinic cholinergic system in the brain. Methods and Findings in Experimental and Clinical Pharmacology 18(1): 41-47

Pharmacological characteristics of an outward current produced by beta-hydroxy-L-glutamic acid on a snail neurone. General Pharmacology 27(3): 499-504

Pharmacological characteristics of endothelin receptors in the rabbit ventricular myocardium: The nonselective endothelin receptor antagonist PD 145065 antagonizes the positive inotropic effect of endothelin-3 but not of endothelin-1. Molecular and Cellular Biochemistry 160-161(0): 67-74

Pharmacological characteristics of indoline derivatives in muscarinic receptor subtypes. Pharmacology 53(4): 250-258

Pharmacological characteristics of neurogenic vasodilator responses in the rat hindquarters. Research Bulletin of Obihiro University Natural Science 19(4): 179-190

Pharmacological characteristics of potassium-induced, glycogenolysis in astrocytes. Neuroscience Letters. 1-2: 45-48

Pharmacological characteristics of tachykinin receptors mediating acetylcholine release from neonatal rat spinal cord. European Journal of Pharmacology 241(1): 105-110

Pharmacological characteristics of the canine cerebrovascular constriction produced by neuropeptide Y. Biological & Pharmaceutical Bulletin 18(4): 501-506

Pharmacological characteristics of the inhibitory action of a new selective alpha-1-adrenoceptor antagonist HV 723 on the positive inotropic effect mediated by alpha-1-adrenoceptors in rabbit ventricular myocardium. Bulletin of the Yamagata University (Medical Science) 11(1): 95-104

Pharmacological characteristics of the long-acting beta-blocker bopindolol. Folia Pharmacologica Japonica 109(1): 1-12

Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine2F receptor. Molecular Pharmacology 43(3): 419-426

Pharmacological characteristics of the positive inotropic effect of angiotensin II in the rabbit ventricular myocardium. British Journal Of Pharmacology. 108(4): 999-1005

Pharmacological characterization and anatomical localization of prejunctional beta-adrenoceptors in the rat kidney. British Journal of Pharmacology 111(4): 1296-1308

Pharmacological characterization and autoradiographic localization of a putative dopamine D4 receptor in the heart. Journal Of Autonomic Pharmacology. 18(2): 115-121, Il

Pharmacological characterization and autoradiographic localization of dihydropyridine-type calcium channels in the kidney of spontaneously hypertensive rats. Clinical & Experimental Pharmacology & Physiology. 22(suppl. 1): S232-S233

Pharmacological characterization and autoradiographic localization of dopamine D-1 receptors in the human umbilical artery. European Journal Of Pharmacology. 234(2-3): 209-214

Pharmacological characterization and autoradiographic localization of dopamine D-1-like receptors in the thymus. Journal Of Neuroimmunology. 50(2): 133-138

Pharmacological characterization and autoradiographic localization of dopamine receptors in human epicardial arteries. Journal of Pharmacology and Experimental Therapeutics 263(3): 1447-1453

Pharmacological characterization and autoradiographic localization of dopamine receptors in the human adrenal cortex. European Journal of Endocrinology 131(1): 91-96

Pharmacological characterization and autoradiographic localization of dopamine receptors in the portal vein. Journal Of Autonomic Pharmacology. 14(1): 61-68

Pharmacological characterization and autoradiographic localization of dopamine receptors in the rat adrenal medulla. European Journal Of Pharmacology. 310(2-3): 129-135

Pharmacological characterization and differentiation of non-cholinergic nucleus basalis neurons in vitro. Neuroreport 9(1): 61-65

Pharmacological characterization and distribution of muscarinic receptors in human placental syncytiotrophoblast brush-border and basal plasma membranes. European Journal Of Pharmacology. 320(2-3): 209-214

Pharmacological characterization and positron emission tomography evaluation of 4-(76Br)bromodexetimide and 4-(76Br)bromolevetimide for investigations of central muscarinic cholinergic receptors. Nuclear Medicine and Biology 23(3): 235-243

Pharmacological characterization and selectivity of the NPY antagonist GR231118 (1229U91) for different NPY receptors. Regulatory Peptides 72(2-3): 113-119

Pharmacological characterization and tissue distribution of the human and rat GALR1 receptors. Biochemical and Biophysical Research Communications 233(3): 823-828

Pharmacological characterization in vitro of prostanoid receptors in the myometrium of nonpregnant ewes. Journal of Reproduction and Fertility 103(1): 55-61

Pharmacological characterization of (3H)idazoxan, (3H)RX821002 and p-(125I) iodoclonidine binding to alpha-2-adrenoceptors in rat cerebral cortical membranes. European Journal of Pharmacology 258(1-2): 67-76

Pharmacological characterization of 1-aminoindan-1,5-dicarboxylic acid, a potent mGluR1 antagonist. Journal of Pharmacology and Experimental Therapeutics 281(2): 721-729

Pharmacological characterization of 5-HT receptors in parasympathetic innervation of rat heart. European Journal Of Pharmacology. 252(2): 161-166

Pharmacological characterization of 5-hydroxytryptamine-induced motor activity (in vitro) in the guinea pig gastric antrum and corpus. European Journal of Pharmacology 308(3): 315-324

Pharmacological characterization of 6-bromo-3'-nitroflavone, a synthetic flavonoid with high affinity for the benzodiazepine receptors. Pharmacology Biochemistry and Behavior 61(3): 239-246

Pharmacological characterization of A-127722: an orally active and highly potent ETA-selective receptor antagonist. Journal of Pharmacology and Experimental Therapeutics 276(2): 473-481

Pharmacological characterization of A2-adenosine receptors in guinea-pig ventricular cardiomyocytes. Journal of Molecular and Cellular Cardiology 26(3): 403-414

Pharmacological characterization of AMPA-induced biting behaviour in mice. European Journal Of Pharmacology. 305(1-3): 115-117

Pharmacological characterization of ATP receptors in ampulla from frog semicircular canal. American Journal of Physiology 275(1 Pt 2): R253-R261

Pharmacological characterization of BNMPA (alpha-benzyl-N-methylphenethylamine), an impurity of illicit methamphetamine synthesis. European Journal of Pharmacology 311(2-3): 133-139

Pharmacological characterization of CCK-B receptors in human brain: No evidence for receptor heterogeneity. Neuroscience Letters 217(1): 45-49

Pharmacological characterization of FK1052, a dihydropyridoindole derivative, as a new serotonin 3 and 4 dual receptor antagonist. Journal of Pharmacology and Experimental Therapeutics 265(2): 752-758

Pharmacological characterization of GR82334, a tachykinin NK-1 receptor antagonist, in the isolated spinal cord of the neonatal rat. European Journal Of Pharmacology. 281(1): 49-54

Pharmacological characterization of GT-2016, a non-thiourea-containing histamine H3 receptor antagonist: in vitro and in vivo studies. Journal of Pharmacology and Experimental Therapeutics 275(2): 598-604

Pharmacological characterization of I-1 and I-2 imidazoline receptors in human striatum. Neurochemistry International. 30(1): 25-29

Pharmacological characterization of KT-90 using cloned mu-, delta- and kappa-opioid receptors. European Journal of Pharmacology 312(3): 349-355

Pharmacological characterization of LY293284: A 5-HT1A receptor agonist with high potency and selectivity. Journal of Pharmacology and Experimental Therapeutics 270(3): 1270-1281

Pharmacological characterization of LY303870: a novel, potent and selective nonpeptide substance P (neurokinin-1) receptor antagonist. Journal of Pharmacology and Experimental Therapeutics 275(2): 737-744

Pharmacological characterization of MCCG and MAP4 at the mGluR1b, mGluR2 and mGluR4a human metabotropic glutamate receptor subtypes. Neuropharmacology. 34(8): 1099-1102

Pharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonist. European Journal Of Pharmacology. 323(2-3): 181-192

Pharmacological characterization of N-methyl-D-aspartate receptors in spinal cord of rats with a chronic peripheral mononeuropathy. Neuropharmacology. 36(11-12): 1561-1569,.-.

Pharmacological characterization of P-2 purinoceptor types in rat locus coeruleus neurons. European Journal Of Pharmacology. 315(3): 255-261

Pharmacological characterization of PD 118717, a putative piperazinyl benzopyranone dopamine autoreceptor agonist. Journal of Pharmacology and Experimental Therapeutics 263(3): 1147-1158

Pharmacological characterization of PD 152255, a novel dimeric benzimidazole dopamine D3 antagonist. Pharmacology Biochemistry & Behavior. 59(2): 487-493,.

Pharmacological characterization of PD 156707, an orally active ETA receptor antagonist. Journal of Pharmacology and Experimental Therapeutics 273(3): 1410-1417

Pharmacological characterization of RS 25259-197, a novel and selective 5-HT-3 receptor antagonist, in vivo. British Journal Of Pharmacology. 114(4): 860-866

Pharmacological characterization of SB 202235, a potent and selective 5-lipoxygenase inhibitor: effects in models of allergic asthma. Journal of Pharmacology and Experimental Therapeutics 273(3): 1147-1155

Pharmacological characterization of SIB-1765F: a novel cholinergic ion channel agonist. Journal of Pharmacology and Experimental Therapeutics 280(1): 373-383

Pharmacological characterization of SR 142801: a new non-peptide antagonist of the neurokinin NK-3 receptor. Pharmacology 52(5): 283-291

Pharmacological characterization of SR 47436, a new nonpeptide AT1 subtype angiotensin II receptor antagonist. Journal of Pharmacology and Experimental Therapeutics 265(2): 826-834

Pharmacological characterization of SR 48692 sensitive neurotensin receptor in human pancreatic cancer cells, MIA PaCa-2. Research Communications in Molecular Pathology and Pharmacology 90(1): 37-47

Pharmacological characterization of Sephadex-induced oedema in rat paws: predominant role of serotonin and platelet-activating factor. International Archives of Allergy and Immunology 109(4): 398-406

Pharmacological characterization of U-101387, a dopamine D4 receptor selective antagonist. Journal of Pharmacology and Experimental Therapeutics 279(3): 1392-1403

Pharmacological characterization of WAY-121,520: A potent anti-inflammatory indomethacin-based inhibitor of 5-lipoxygenase (5-LO)/phospholipase A-2 (PLA-2). Agents and Actions 39(SPEC. CONF. ISSUE): C30-C32

Pharmacological characterization of YM087, a potent, nonpeptide human vasopressin V1A and V2 receptor antagonist. Naunyn-Schmiedeberg's Archives of Pharmacology 357(1): 63-69

Pharmacological characterization of a Chinese hamster ovary cell line transfected with the human CCK-B receptor gene. Neuropeptides. 30(4): 359-363

Pharmacological characterization of a cloned rat glutamate transporter (GluT-1). Molecular Brain Research 21(1-2): 167-170

Pharmacological characterization of a new class of nonpeptide neurokinin A antagonists that demonstrate species selectivity. Journal of Pharmacology and Experimental Therapeutics 274(3): 1216-1221

Pharmacological characterization of a new milrinone analogue. Farmaco 49(1): 19-23

Pharmacological characterization of a new purinergic receptor site in rabbit aorta. General Pharmacology. 23(6): 1067-1071

Pharmacological characterization of a nicotinic autoreceptor in rat hippocampal synaptosomes. Neurochemical Research. 21(9): 1141-1148

Pharmacological characterization of a novel long-acting histamine H1 receptor antagonist, KAA-276. Biological & Pharmaceutical Bulletin 21(4): 350-355

Pharmacological characterization of a novel, orally active, nonpeptide bradykinin B-2 receptor antagonist, FR167344. European Journal Of Pharmacology. 333(1): 79-86

Pharmacological characterization of a potent nonpeptide endothelin receptor antagonist, 97-139. Journal of Pharmacology and Experimental Therapeutics 268(3): 1122-1128

Pharmacological characterization of a receptor for platelet-activating factor in guinea pig peritoneal macrophages using (3H) apafant, a selective and competitive platelet-activating factor antagonist: Evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation. Molecular Pharmacology 43(2): 302-312

Pharmacological characterization of a serotonin receptor involved in an early embryonic behavior of Helisoma trivolvis. Journal of Neurobiology 25(12): 1545-1557

Pharmacological characterization of a simple behavioral response mediated selectively by central adenosine A1 receptors, using in vivo and in vitro techniques. Journal of Pharmacology and Experimental Therapeutics 285(3): 1023-1030

Pharmacological characterization of a specific binding site for angiotensin IV in cultured porcine aortic endothelial cells. European Journal Of Pharmacology. 305(1-3): 199

Pharmacological characterization of a vasopressin V1 receptor in the isolated human gastric artery. Life Sciences 60(4-5): Pl63-Pl68

Pharmacological characterization of acetylcholine-stimulated (sulfur-35)-GTP-gamma-S binding mediated by human muscarinic m1-m4 receptors: Antagonist studies. British Journal of Pharmacology 109(4): 1120-1127

Pharmacological characterization of adenosine A2B receptors. Biochemical Pharmacology 55(5): 627-633, March 1

Pharmacological characterization of adrenoceptors in horse corpus cavernosum penis. Journal Of Autonomic Pharmacology. 17(3): 198

Pharmacological characterization of alpha-1-adrenoceptor subtype mediating regulation of arterial pressure and urethral perfusion pressure in the anaesthetized rat. Journal Of Autonomic Pharmacology. 16(4): 203

Pharmacological characterization of alpha-adrenoceptors that mediate contraction in splenic artery strips from the pig. Naunyn-Schmiedeberg's Archives of Pharmacology 357(6): 654-661

Pharmacological characterization of an FP prostaglandin receptor on rat vascular smooth muscle cells (A7r5) coupled to phosphoinositide turnover and intracellular calcium mobilization. Journal of Pharmacology and Experimental Therapeutics 286(1): 411-418

Pharmacological characterization of an alpha-1A-adrenoceptor mediating contractile responses to noradrenaline in isolated caudal artery of rat. British Journal of Pharmacology 120(5): 819-826

Pharmacological characterization of an operant discrimination among two doses of morphine and saline in pigeons. Behavioural Pharmacology 6(7): 669-681

Pharmacological characterization of an opioid receptor in the ciliate Tetrahymena. Journal Of Eukaryotic Microbiology. 40(6): 800-804

Pharmacological characterization of benzodiazepine receptor ligands with intrinsic efficacies ranging from high to zero. Psychopharmacology. 111(4): 415-422

Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. Journal of Pharmacology and Experimental Therapeutics 270(1): 228-235

Pharmacological characterization of bradykinin receptors coupled to phosphoinositide turnover in SV40-immortalized human trabecular meshwork cells. Experimental Eye Research 63(6): 631-637

Pharmacological characterization of bradykinin receptors in canine cultured tracheal smooth muscle cells. British Journal Of Pharmacology. 114(1): 67-72

Pharmacological characterization of calcium currents and synaptic transmission between thalamic neurons in vitro. Journal of Neuroscience 12(11): 4347-4357

Pharmacological characterization of cardiovascular responses induced by endothelin-1 in the perfused rat heart. European Journal Of Pharmacology. 296(1): 65-74

Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A-2 receptor. British Journal of Pharmacology 111(3): 906-912

Pharmacological characterization of cloned human NK-2 (neurokinin A) receptor expressed in a baculovirus/Sf-21 insect cell system. Molecular Pharmacology 44(2): 356-363

Pharmacological characterization of coronary small arteries from pigs with chronic ischaemic myocardial remodelling. Clinical Science 94(2): 141-147

Pharmacological characterization of effects of verapamil and GS 283 on isolated guinea pig and rat trachealis. European Journal Of Pharmacology. 236(1): 51-60

Pharmacological characterization of endomorphin-1 and endomorphin-2 in mouse brain. Journal of Pharmacology and Experimental Therapeutics 286(2): 1007-1013

Pharmacological characterization of endothelial cell nitric oxide synthase inhibitors in isolated rabbit aorta. Life Sciences. 62(6): 479-490,. 2

Pharmacological characterization of epinephrine-stimulated GTPase activity in human platelet membranes. Biochemical Pharmacology. 46(11): 2021-2028

Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines. Molecular Pharmacology 45(6): 1227-1234

Pharmacological characterization of glial cell line-derived neurotrophic factor (GDNF): Implications for GDNF as a therapeutic molecule for treating neurodegenerative diseases. Cell and Tissue Research 286(2): 179-189

Pharmacological characterization of glutamate binding sites in cultured cerebellar granule cells and cortical astrocytes. Neurochemical Research. : 111-115

Pharmacological characterization of glutamate receptors in muscles of the locust Locusta migratoria. Zhurnal Evolyutsionnoi Biokhimii i Fiziologii 30(3): 377-385

Pharmacological characterization of grooming induced by a selective NK-1 tachykinin receptor agonist. Brain Research. 700(1-2): 115-120

Pharmacological characterization of guanidinoethyldisulphide (GED), a novel inhibitor of nitric oxide synthase with selectivity towards the inducible isoform. British Journal of Pharmacology 118(7): 1659-1668

Pharmacological characterization of heterodimeric NMDA receptors composed of NR 1a and 2B subunits: Differences with receptors formed from NR 1a and 2A. Journal of Neurochemistry 64(4): 1462-1468

Pharmacological characterization of heterologously expressed ATP-gated cation channels (P2x purinoceptors). Molecular Pharmacology 48(2): 178-183

Pharmacological characterization of histamine H-3 receptors in isolated guinea pig pulmonary artery and ileum. European Journal Of Pharmacology. 294(1): 329-335

Pharmacological characterization of human histamine H-2 receptor stably expressed in Chinese hamster ovary cells. British Journal of Pharmacology 112(3): 847-854

Pharmacological characterization of human m1 muscarinic acetylcholine receptors with double mutations at the junction of TM VI and the third extracellular domain. Journal of Pharmacology and Experimental Therapeutics 286(3): 1129-1139

Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats. Journal of Pharmacology and Experimental Therapeutics 282(2): 747-759

Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT2A/2C antagonist anxiolytics. I. Antipunishment effects in the pigeon. Journal of Pharmacology and Experimental Therapeutics 276(2): 388-397

Pharmacological characterization of inward current evoked by N-methyl-D-aspartate in dopamine neurons in the rat brain slice. Journal of Pharmacology and Experimental Therapeutics 279(2): 457-463

Pharmacological characterization of ionotropic excitatory amino acid receptors in young and aged rat basal forebrain. Neuroscience 82(4): 1179-1194

Pharmacological characterization of kinin-induced relaxation of human corpus cavernosum. Bju. 81(3): 432-436, Ch

Pharmacological characterization of large conductance calcium-activated potassium channels in N 1 E-115 cells and effects of trypsin. Travaux Scientifiques des Chercheurs du Service de Sante des Armees 0(15): 117-118

Pharmacological characterization of linear analogues of vasopressin generated by the systematic substitution of positions 1 and 6 by L-amino acids. Biochemical Pharmacology. 47(9): 1497-1501

Pharmacological characterization of lower esophageal sphincter relaxation induced by swallowing, vagal efferent nerve stimulation, and esophageal distention. Canadian Journal of Physiology and Pharmacology 70(7): 1011-1015

Pharmacological characterization of metabotropic glutamate receptors coupled to phospholipase D in the rat hippocampus. British Journal Of Pharmacology. 118(4): 1035-1043

Pharmacological characterization of metabotropic glutamate receptors in cultured cerebellar granule cells. Neurochemical Research. 18(5): 605-612

Pharmacological characterization of metabotropic glutamate receptors in several types of brain cells in primary cultures. Molecular Pharmacology 45(4): 570-577

Pharmacological characterization of metabotropic glutamate receptors linked to the inhibition of adenylate cyclase activity in rat striatal slices. Neuropharmacology. 36(7): 933-940

Pharmacological characterization of metabotropic glutamate receptors potentiating NMDA responses in mouse cortical wedge preparations. British Journal Of Pharmacology. 118(6): 1530-1536

Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Research 54(22): 5902-5910

Pharmacological characterization of muscarinic acetylcholine binding sites in human and bovine cerebral microvessels. Naunyn-Schmiedeberg'S Archives Of Pharmacology. 352(2): 179-186

Pharmacological characterization of muscarinic cholinergic receptors in cat pons and cortex. Pharmacology (Basel) 48(2): 77-85

Pharmacological characterization of muscarinic receptors in neonatal rat cardiomyocytes. American Journal of Physiology 265(3 Pt 1): C666-C673

Pharmacological characterization of muscarinic receptors mediating acetylcholine-induced contraction and relaxation in rabbit intrapulmonary arteries. Journal of Pharmacology and Experimental Therapeutics 270(1): 269-276

Pharmacological characterization of nerve growth factor and/or monosialoganglioside GM1 effects on cholinergic markers in the adult lesioned brain. Journal of Pharmacology and Experimental Therapeutics 272(2): 527-545

Pharmacological characterization of neuronal acetylcholine gated ion channel receptor-mediated hippocampal norepinephrine and striatal dopamine release from rat brain slices. Journal of Pharmacology and Experimental Therapeutics 274(1): 224-230

Pharmacological characterization of neuropeptide Y-(2-36) binding to neuropeptide Y Y-1 and Y-2 receptors. European Journal of Pharmacology 318(2-3): 307-313

Pharmacological characterization of new cholecystokinin analogues. European Journal Of Pharmacology. 222(2-3): 233-240

Pharmacological characterization of nitric oxide production in a rat model of meningitis. Neuropharmacology. 35(2): 231-237

Pharmacological characterization of nociceptin receptor: An in vitro study. Canadian Journal of Physiology and Pharmacology 75(6): 713-718

Pharmacological characterization of noradrenaline-induced contractions of the porcine isolated palmar lateral vein and palmar common digital artery. British Journal Of Pharmacology. 114(3): 694-702

Pharmacological characterization of novel tissue kallikrein inhibitors in vivo. Immunopharmacology. 32(1-3): 111-114

Pharmacological characterization of orphanin FQ/nociceptin and its fragments. Journal of Pharmacology and Experimental Therapeutics 282(2): 858-865

Pharmacological characterization of oxytocin-binding sites in rat spinal cord membranes: Comparison with embryonic cultured spinal cord neurones and astrocytes. Journal of Neuroendocrinology 9(7): 553-560

Pharmacological characterization of performance on a concurrent lever pressing/feeding choice procedure: Effects of dopamine antagonist, cholinomimetic, sedative and stimulant drugs. Psychopharmacology 116(4): 529-537

Pharmacological characterization of phenytoin-resistant amygdala-kindled rats, a new model of drug-resistant partial epilepsy. Epilepsy Research. 15(3): 207-219

Pharmacological characterization of pre- and postsynaptic GABA-B receptors in the deep nuclei of rat cerebellar slices. Neuroscience. 68(4): 1127-1137

Pharmacological characterization of presynaptic calcitonin gene-related peptide (CGRP) receptors on CGRP-containing vasodilator nerves in rat mesenteric resistance vessels. Journal of Pharmacology and Experimental Therapeutics 268(1): 59-64

Pharmacological characterization of presynaptic calcium channels using subsecond biochemical measurements of synaptosomal neurosecretion. Neuropharmacology. 34(11): 1469-1478

Pharmacological characterization of presynaptic calcium currents underlying glutamatergic transmission in the avian auditory brainstem. Journal of Neuroscience 15(10): 6576-6585

Pharmacological characterization of protease-activated receptor (PAR-1) in rat astrocytes. European Journal of Pharmacology 323(1): 111-117

Pharmacological characterization of purinoceptor-mediated constriction of submucosal arterioles in guinea pig ileum. Journal of Pharmacology and Experimental Therapeutics 274(3): 1425-1430

Pharmacological characterization of rabbit corpus cavernosum relaxation mediated by the tissue kallikrein-kinin system. British Journal Of Pharmacology. 113(1): 81-86

Pharmacological characterization of serotonin receptor in the oocyte membrane of bivalve molluscs and its formation during oogenesis. Journal Of Experimental Zoology. 281(2): 124-131, E 1

Pharmacological characterization of serotonin synthesis and uptake suggest a false transmitter role for serotonin in the pituitary intermediate lobe. Neuroscience Research. 21(2): 143-149

Pharmacological characterization of somatostatin receptors in rat cerebellar nuclei. European Journal Of Pharmacology. 271(1): 79-86

Pharmacological characterization of stably transfected Na+/H+ antiporter isoforms using amiloride analogs and a new inhibitor exhibiting anti-ischemic properties. Molecular Pharmacology 44(5): 1041-1045

Pharmacological characterization of synaptic transmission through mGluRs in rat cerebellar slices. Neuropharmacology. 36(3): 401-403

Pharmacological characterization of tachykinin NK2 receptors on isolated human urinary bladder, prostatic urethra and prostate. Journal of Pharmacology and Experimental Therapeutics 277(2): 700-705

Pharmacological characterization of tachykinin receptors controlling acetylcholine release from rat striatum: An in vivo microdialysis study. Journal of Neurochemistry 65(6): 2543-2548

Pharmacological characterization of tachykinin-induced intracellular calcium rise in a human NK2 receptor transfected cell line. Biochemical and Biophysical Research Communications 200(3): 1512-1520

Pharmacological characterization of the 5-hydroxytryptamine receptor coupled to adenylyl cyclase stimulation in human brain. Life Sciences. 52(9): Pl61-Pl65

Pharmacological characterization of the 5-hydroxytryptamine receptor mediating relaxation in the rat isolated ileum. British Journal Of Pharmacology. 119(2): 303-310

Pharmacological characterization of the 5-hydroxytryptamine-1A receptor-mediated activation of high-affinity GTP hydrolysis in rat hippocampal membranes. Journal of Pharmacology and Experimental Therapeutics 274(1): 337-344

Pharmacological characterization of the ET-A receptor in the vascular smooth muscle comparing its analogous distribution in the rat mesenteric artery and in the arterial mesenteric bed. Peptides (tarrytown). 17(7): 1145-1153

Pharmacological characterization of the activity of endogenous inotropic factor from porcine left ventricle. Journal of Cardiovascular Pharmacology 22 Suppl 2: S93-S95

Pharmacological characterization of the afterdischarge that precedes the onset of maximal dentate activation in the rat. Neuropharmacology. 33(5): 625-633

Pharmacological characterization of the apparent splice variants of the murine 5-HT-3 R-A subunit expressed in Xenopus laevis oocytes. Neuropharmacology. 33(3-4): 473-482

Pharmacological characterization of the cloned human 5-hydroxytryptamine transporter. Biochemical Pharmacology. 51(9): 1145-1151

Pharmacological characterization of the cloned kappa opioid receptor as a kappa-1b subtype. Neuroreport 5(16): 2161-2164

Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors. Molecular Pharmacology 45(2): 330-334

Pharmacological characterization of the discriminative stimulus effects of clenbuterol in rats. Pharmacology Biochemistry & Behavior. 58(3): 813-818

Pharmacological characterization of the dopamine receptor coupled to cyclic AMP formation expressed by rat mesenteric artery vascular smooth muscle cells in culture. British Journal Of Pharmacology. 110(2): 681-686

Pharmacological characterization of the effects of taurine on calcium uptake in the rat retina. Amino Acids (vienna). 15(1-2): 99-108

Pharmacological characterization of the enhancement of apomorphine-induced gnawing in mice by cocaine. Pharmacology Biochemistry & Behavior. 55(1): 135-140

Pharmacological characterization of the human P-2Y4 receptor. European Journal Of Pharmacology. 317(2-3): 383-389

Pharmacological characterization of the human ionotropic glutamate receptor subtype GluR3 stably expressed in mammalian cells. Journal of Pharmacology and Experimental Therapeutics 285(1): 358-370

Pharmacological characterization of the inhibitory effect of (R)-alpha-methylhistamine on sympathetic cardiopressor responses in the pithed guinea-pig. Journal of Autonomic Pharmacology 14(6): 393-402

Pharmacological characterization of the inwardly-rectifying current in the smooth muscle cells of the rat bladder. British Journal Of Pharmacology. 119(8): 1509-1518

Pharmacological characterization of the isolated canine prostate. Journal Of Urology. 155(5): 1758-1761

Pharmacological characterization of the locust neuronal 3H-mianserin binding site, a putative histamine receptor. Comparative Biochemistry & Physiology C Comparative Pharmacology & Toxicology. 106(2): 503-507

Pharmacological characterization of the mouse paw edema induced by staphylococcal enterotoxin B. Journal of Natural Toxins 5(1): 61-71

Pharmacological characterization of the murine and human orthologs of multidrug-resistance protein in transfected human embryonic kidney cells. Molecular Pharmacology 52(3): 344-353

Pharmacological characterization of the muscarinic receptor subtype mediating contraction of human peripheral airways. Journal of Pharmacology and Experimental Therapeutics 274(3): 1293-1297

Pharmacological characterization of the muscarinic receptor subtypes responsible for the contractile response in the rat urinary bladder. Journal Of Autonomic Pharmacology. 17(1): 21-25

Pharmacological characterization of the nonpeptide angiotensin II receptor antagonist, U-97018. Journal of Pharmacology and Experimental Therapeutics 274(3): 1042-1053

Pharmacological characterization of the novel anxiolytic beta-carboline abecarnil in rodents and primates. Japanese Journal of Pharmacology 64(3): 179-187

Pharmacological characterization of the novel cholinomimetic L-689,660 at cloned and native brain muscarinic receptors. Journal of Pharmacology and Experimental Therapeutics 267(3): 1478-1483

Pharmacological characterization of the novel discriminative stimulus effects of a low dose of cocaine. Journal of Pharmacology and Experimental Therapeutics 270(3): 1041-1048

Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277. British Journal Of Pharmacology. 110(1): 245-252

Pharmacological characterization of the nucleotide receptors that mobilize Ca2+ ions in human parathyroid cells. Journal of Endocrinology 142(2): 277-283

Pharmacological characterization of the pressor response to tachykinins in isolated perfused rat kidney. Journal of Pharmacology and Experimental Therapeutics 267(3): 1176-1180

Pharmacological characterization of the pseudopterosins: Novel anti-inflammatory natural products isolated from the Caribbean soft coral, Pseudopterogorgia elisabethae. Life Sciences 62(26): PL401-PL407

Pharmacological characterization of the rat A2a adenosine receptor functionally coupled to the yeast pheromone response pathway. Molecular Pharmacology 50(4): 829-837

Pharmacological characterization of the rat cerebellar endothelin-B (ET-B) receptor using the novel agonist radioligand (125I)BQ3020. Brain Research 665(1): 33-38

Pharmacological characterization of the rat hippocampal muscarinic autoreceptor. Journal of Pharmacology and Experimental Therapeutics 264(1): 74-78

Pharmacological characterization of the receptors involved in the beta-adrenoceptor-mediated stimulation of the L-type Ca2+ current in frog ventricular myocytes. British Journal of Pharmacology 121(7): 1277-1286

Pharmacological characterization of the release of neuropeptide Y-like immunoreactivity from the rat hypothalamus. Neuropharmacology. 32(8): 819-825

Pharmacological characterization of the renovascular P2 purinergic receptors. Journal of Pharmacology and Experimental Therapeutics 265(1): 334-338

Pharmacological characterization of the rhythmic synaptic drive onto lumbosacral motoneurons in the chick embryo spinal cord. Journal of Neuroscience 15(11): 7452-7464

Pharmacological characterization of the selective nonpeptide neuropeptide Y Y1 receptor antagonist BIBP 3226. Journal of Pharmacology and Experimental Therapeutics 275(1): 136-142

Pharmacological characterization of the uroselective alpha-1 antagonist Rec 15/2739 (SB 216469): Role of the alpha-1L adrenoceptor in tissue selectivity: Part II. Journal of Pharmacology and Experimental Therapeutics 281(3): 1284-1293

Pharmacological characterization of the vanilloid receptor in the rat isolated vas deferens. Journal Of Pharmacy & Pharmacology. 48(3): 285-291

Pharmacological characterization of the vasodilator effect of DF-100, a new pyridazino(4,5-b)indole, in vascular smooth muscle. Journal of Cardiovascular Pharmacology 21(1): 89-94

Pharmacological characterization of the vesamicol analogue (+)-(125I)MIBT in primate brain. European Journal of Pharmacology 338(2): 159-169

Pharmacological characterization of the voltage-dependent Ca-2+ channels present in synaptosomes from rat and chicken central nervous system. Journal Of Neurochemistry. 64(6): 2544-2551

Pharmacological characterization of three novel cannabinoid receptor agonists in the mouse isolated vas deferens. European Journal Of Pharmacology. 284(3): 241-247

Pharmacological characterization of two novel and potent 5-HT-4 receptor agonists, RS 67333 and RS 67506, in vitro and in vivo. British Journal Of Pharmacology. 115(8): 1387-1392

Pharmacological characterization of type 1-alpha metabotropic glutamate receptor-stimulated (35S)-GTP-gamma-S binding. British Journal of Pharmacology 121(6): 1203-1209

Pharmacological characterization of voltage-sensitive calcium channels in autonomic nerves. European Journal of Pharmacology 231(2): 197-202

Pharmacological characterization, anatomical distribution and sex differences of the non-NMDA excitatory amino acid receptors in the quail brain as identified by CNQX binding. Journal Of Chemical Neuroanatomy. 15(3): 187-200,.

Pharmacological choices after one antidepressant fails: A survey of UK psychiatrists. Journal of Affective Disorders 43(1): 19-25

Pharmacological classical conditioning in humans. Human Psychopharmacology. 12(4): 369-377

Pharmacological classification and renal actions of diuretics. Cardiology 84 Suppl 2: 4-13

Pharmacological classification of alpha-1-adrenoceptors mediating contractions of rabbit isolated ear artery: Comparison with rat isolated thoracic aorta. British Journal of Pharmacology 120(2): 247-258

Pharmacological classification of central post-stroke pain: Comparison with the results of chronic motor cortex stimulation therapy. Pain 72(1-2): 5-12

Pharmacological comparison of the cloned human and rat M2 muscarinic receptor genes expressed in the murine fibroblast (B82) cell line. Journal of Pharmacology and Experimental Therapeutics 284(2): 500-507

Pharmacological comparison of the stereoisomers of glyceryl-1-nitrate. Arzneimittel-Forschung 44(4): 474-477

Pharmacological consequences of nicotinergic plus serotonergic manipulations. Brain Research. 622(1-2): 139-146

Pharmacological considerations in high-dose chemotherapy. Cancer Chemotherapy & Pharmacology. 40(suppl.): S115-S118

Pharmacological control of P-glycoprotein expression. Bulletin du Cancer 81(5): 386-391

Pharmacological control of allergy at the stage of IgE antibody production. Khimiko-Farmatsevticheskii Zhurnal 27(2): 4-7

Pharmacological control of calcium channels and muscle contractility. Biomedical Research (Tokyo) 14(SUPPL 2): 65-70

Pharmacological control of facilitatory I-wave interaction in the human motor cortex: A paired transcranial magnetic stimulation study. Electroencephalography and Clinical Neurophysiology 109(4): 321-330

Pharmacological control of human polymorphonuclear leukocyte degranulation by fenamates and inhibitors of receptor-mediated calcium entry and protein kinase C. Biochemical Pharmacology. 50(2): 203

Pharmacological control of intimal hyperplasia in small diameter polytetrafluoroethylene grafts. An experimental study. International Angiology 15(1): 50-56

Pharmacological control of lung metastases of solid tumours by a novel ruthenium complex. Clinical & Experimental Metastasis. 16(4): 371-379,

Pharmacological control of pulmonary blood flow with inhaled nitric oxide after the fenestrated Fontan operation. Circulation 94(9 Suppl): Ii44-Ii48

Pharmacological control of the mevalonate biosynthetic pathway: Effect on arterial smooth muscle cell proliferation. Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 191(2): 169-194

Pharmacological control of the mevalonate pathway: effect on arterial smooth muscle cell proliferation. Journal of Pharmacology and Experimental Therapeutics 281(3): 1144-1153

Pharmacological correlation between total drug concentration and lactones of CPT-11 an SN-38 in patients treated with CPT-11. Japanese Journal of Cancer Research 86(1): 111-116

Pharmacological coupling and functional role for CGRP receptors in the vasodilation of rat pial arterioles. American Journal of Physiology 270(1 Pt 2): H317-H323

Pharmacological data on Advocid 2.5 percent. A new fluoroquinolone antiinfective agent. Tieraerztliche Umschau 51(9): 567-575

Pharmacological defense of the brain during radiation damage: Some arguments. Aviakosmicheskaya i Ekologicheskaya Meditsina 26(2): 6-11

Pharmacological demonstration of a barrier for protease, peptides and acetylcholine in the endometrium of the rat. Archives Internationales de Pharmacodynamie et de Therapie 326: 95-100

Pharmacological demonstration of the additive effects of angiotensin-converting enzyme inhibition and angiotensin II antagonism in sodium depleted healthy subjects. Clinical and Experimental Hypertension 19(5-6): 937-951

Pharmacological differences between calcium antagonists. European Heart Journal 18 Suppl A: A71-A79

Pharmacological differences between kynurenine- and corasole-induced convulsions (participation of GABAB-receptors and dopamine). Eksperimental'naya i Klinicheskaya Farmakologiya 61(2): 20-22

Pharmacological differences between rat and human endothelin B receptors. Biochemical and Biophysical Research Communications 209(2): 506-512

Pharmacological differentiation between intracellular calcium pump isoforms. Molecular Pharmacology 50(5): 1243-1252

Pharmacological differentiation between neuronal and recombinant glutamate receptor channels expressed in Xenopus oocytes. Neuropharmacology. 36(11-12): 1489-1501,.-.

Pharmacological differentiation of classical and novel antipsychotics. International Clinical Psychopharmacology 13 Suppl 3: S7-14

Pharmacological differentiation of human 5-HT1B and 5-HT1D receptors. Biological Signals 3(5): 217-222

Pharmacological differentiation of metabotropic glutamate receptors coupled to potentiation of cyclic adenosine monophosphate responses and phosphoinositide hydrolysis. Journal of Pharmacology and Experimental Therapeutics 266(2): 518-525

Pharmacological differentiation of synergistic contribution of L-type Ca2+ channels and Na+/H+ exchange to the positive inotropic effect of phenylephrine, endothelin-3 and angiotensin II in rabbit ventricular myocardium. Naunyn-Schmiedeberg's Archives of Pharmacology 355(1): 87-96

Pharmacological differentiation of the effects of co-activation of beta-adrenergic and metabotropic glutamate receptors in rat hippocampus. Neuroscience Letters 186(2-3): 119-122

Pharmacological discrimination between gamma-aminobutyric acid type B receptors regulating cholecystokinin and somatostatin release from rat neocortex synaptosomes. Molecular Pharmacology 46(3): 558-562

Pharmacological discrimination of GluR5 and GluR6 kainate receptor subtypes by (3S,4aR,6R,8aR)-6-(2-(1(2)H-tetrazole-5-yl)ethyl)decahydroisoquinoline-3 carboxylic-acid. Molecular Pharmacology 49(4): 581-585

Pharmacological disruption of hair follicle pigmentation by cyclophosphamide as a model for studying the melanocyte response to and recovery from cytotoxic drug damage in situ. Journal Of Investigative Dermatology. 106(6): 1203-1211

Pharmacological dissection of multiple types of Ca2+ channel currents in rat cerebellar granule neurons. Journal of Neuroscience 15(4): 2995-3012

Pharmacological dissociation of UTP- and ATP-elicited contractions and relaxations in isolated rat aorta. European Journal Of Pharmacology. 294(2-3): 521-529

Pharmacological dissociation of glutamatergic metabotropic signal transduction pathways in cortical astrocytes. European Journal Of Pharmacology Molecular Pharmacology Section. 17(2): 235-241

Pharmacological dissociation of responses to CCK and gastric loads in rat mechanosensitive vagal afferents. American Journal of Physiology 267(1 Pt 2): R303-R308

Pharmacological dissociation of the motor and electrical aspects of convulsive status epilepticus induced by the cholinesterase inhibitor soman. Epilepsy Research. 14(2): 95-103

Pharmacological distinction between dantrolene and ryanodine binding sites: evidence from normal and malignant hyperthermia-susceptible porcine skeletal muscle. Biochemical Journal 326: 847-852

Pharmacological distinction of the hyperpolarization response to caffeine and acetylcholine in guinea-pig coronary endothelial cells. European Journal Of Pharmacology. 223(1): 33-38

Pharmacological dose of estradiol-17beta induces vitellogenin synthesis in cultured hepatocytes of immature Eel Anguilla japonica. Fisheries Science (Tokyo) 63(6): 989-994, Dec

Pharmacological doses of insulin equalize insulin receptor phosphotyrosine content but not tyrosine kinase activity in plasmalemmal and endosomal membranes. Biochemistry & Cell Biology. 70(10-11): 1151-1158

Pharmacological effect of betapressin in hypertensive patients. Eksperimental'naya i Klinicheskaya Farmakologiya 59(6): 23-25

Pharmacological effect of ethanol on the function of rabbit corporal cavernosal tissue. Pharmacology 48(5): 335-340

Pharmacological effect of recombinant human colony-stimulating factor (rhG-CSF) after administration into rat large intestine. International Journal of Pharmaceutics (Amsterdam) 110(1): 47-53

Pharmacological effects and pathological changes induced by the venom of Pseudechis australis in isolated skeletal muscle preparations. Toxicon. 32(3): 303-315

Pharmacological effects of 5-fluorouracil microspheres on peritoneal carcinomatosis in animals. British Journal of Cancer 74(9): 1392-1396

Pharmacological effects of Azadirachta indica (neem) leaf extract on the ECG and blood pressure of rat. Indian Journal of Physiology and Pharmacology 38(3): 223-225

Pharmacological effects of GR138950, a novel angiotensin AT1 receptor antagonist. Journal of Pharmacology and Experimental Therapeutics 272(2): 750-757

Pharmacological effects of SA96 (bucillamine) and its metabolites as immunomodulating drugs--the disulfide structure of SA-96 metabolites plays a critical role in the pharmacological action of the drug. International Journal of Immunopharmacology 20(6): 295-304

Pharmacological effects of SB 220025, a selective inhibitor of P38 mitogen-activated protein kinase, in angiogenesis and chronic inflammatory disease models. Journal of Pharmacology and Experimental Therapeutics 284(2): 687-692

Pharmacological effects of zisu and baisu. Zhongguo Zhong Yao Za Zhi 22(1): 48-51, 63

Pharmacological effects of antiarrhythmic drugs. Archives of Internal Medicine 158(4): 325-332, Feb 23

Pharmacological effects of carboplatin-liposomes (CPL) in mice: A review of present knowledge. Journal of Liposome Research 5(1): 75-89

Pharmacological effects of cefclidin on the central nervous system. Japanese Journal of Antibiotics 46(1): 18-30

Pharmacological effects of concomitant administration of beta-adrenoceptor blocker and agonist in normal subjects: characterization by heart rate response to exercise. Effects of beta-blocker combined with beta-agonist. European Journal of Clinical Pharmacology 48(6): 467-471

Pharmacological effects of epibatidine optical enantiomers. Brain Research. 664(1-2): 34-40

Pharmacological effects of ibudilast on cerebral circulation: a PET study. Neurological Research 15(3): 169-173

Pharmacological effects of melatonin treatment on both locomotor activity and brain serotonin release in rats. Journal Of Pineal Research. 17(1): 11-16

Pharmacological effects of orotyl-(L)-seryl-(L)-arginyl-glycyl-(L)-aspartyl-(L)-tryptophan (NSL-9403), an anti-platelet agent, on respiratory, cardiovascular, autonomic nervous, gastrointestinal and genitourinary systems, neuromuscular junction and blood coagulation. Oyo Yakuri 51(4): 175-186

Pharmacological effects of oximes: How relevant are they?. Archives of Toxicology 70(12): 779-786

Pharmacological effects of phosphatidylserine enzymatically synthesized from soybean lecithin on brain functions in rodents. Journal of Nutritional Science and Vitaminology 42(1): 47-54

Pharmacological effects of selected flavonoids on rat isolated ileum: structure-activity relationship. General Pharmacology 28(5): 767-771

Pharmacological effects of the new gastroprokinetic agent mosapride citrate and its metabolites in experimental animals. Arzneimittel-Forschung 43(10): 1078-1083

Pharmacological effects of the non-competitive NMDA antagonist CNS 1102 in normal volunteers. British Journal Of Clinical Pharmacology. 38(1): 33-38

Pharmacological effects of zotepine and other antipsychotics on central 5-HT-2 receptors. Pharmacopsychiatry 26(2): 53-58

Pharmacological elevation of blood pressure in acute stroke. Clinical effects and safety. Stroke 28(11): 2133-2138

Pharmacological enhancement of hypoxia tolerance: Interest of modafinil. Travaux Scientifiques des Chercheurs du Service de Sante des Armees 0(15): 195-196

Pharmacological enhancement of in vivo foreign gene expression in muscle. Gene Therapy 1(2): 114-121

Pharmacological evaluation of (11C)A-84543: An enantioselective ligand for in vivo studies of neuronal nicotinic acetylcholine receptors. Life Sciences 63(1): PL13-PL18

Pharmacological evaluation of 1229U91, a novel high-affinity and selective neuropeptide Y-Y1 receptor antagonist. Journal of Pharmacology and Experimental Therapeutics 275(3): 1261-1266

Pharmacological evaluation of 2-amino-6(7)- and 9-amino-6-trifluoromethylbenzonorbornenes, the conformationally rigid analogues of norfenfluramine in mice. General Pharmacology 24(6): 1343-1349

Pharmacological evaluation of N-methyl-actinodaphnine, a new vascular alpha-adrenoceptor antagonist, isolated from Illigera luzonensis. European Journal of Pharmacology 279(1): 33-41

Pharmacological evaluation of UK-14,304 analogs at cloned human alpha adrenergic receptors. Bioorganic & Medicinal Chemistry Letters 5(19): 2255-2258

Pharmacological evaluation of a modified open-field test sensitive to anxiolytic drugs. Pharmacology Biochemistry & Behavior. 59(3): 677-683, Ch

Pharmacological evaluation of a new timolol/pilocarpine formulation. Ophthalmic Research 30(2): 101-106

Pharmacological evaluation of combined PGI-2 agonists/thromboxane synthase inhibitors: I. Bioorganic and Medicinal Chemistry Letters 5(10): 1087-1090

Pharmacological evaluation of leukotriene biosynthesis and inflammation in an adoptive model of peritoneal anaphylaxis in the mouse. Drug Development Research. 30(2): 83-90

Pharmacological evaluation of methylcarbamylcholine-induced drinking behavior in rats. Pharmacology Biochemistry & Behavior. 49(1): 1-6

Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galanthamine. Journal of Pharmacology and Experimental Therapeutics 277(2): 728-738

Pharmacological evaluation of ofloxacin. Chinese Journal of Antibiotics 18(3): 218-223

Pharmacological evaluation of selected, orally active, peptidyl inhibitors of human neutrophil elastase. Journal of Pharmacology and Experimental Therapeutics 275(3): 1233-1238

Pharmacological evaluation of the alpha-adrenoceptors of the rabbit urethra. European Urology 24(1): 144-147

Pharmacological evaluation of the cholinergic system in progressive supranuclear palsy. Annals of Neurology 36(1): 55-61

Pharmacological evidence for GABAergic and glutamatergic involvement in the convulsant and behavioral effects of glutaric acid. Brain Research. 802(1-2): 55-60,. 17

Pharmacological evidence for a lack of role for protein kinase C in staurosporine-induced morphological changes in embryonic Xenopus myocytes. European Journal Of Pharmacology Environmental Toxicology & Pharmacology Section. 3(4): 321-330

Pharmacological evidence for a receptor mediating sustained nucleotide-evoked contractions of rat aorta in the presence of UTP. European Journal Of Pharmacology. 349(2-3): 225-235, 22

Pharmacological evidence for a role of long-term potentiation in memory. Faseb Journal 8(14): 1139-1145

Pharmacological evidence for a single bradykinin B-2 receptor in the guinea-pig. British Journal Of Pharmacology. 116(3): 2106-2112

Pharmacological evidence for an involvement of group II and group III mGluRs in the presynaptic regulation of excitatory synaptic responses in the CA1 region of rat hippocampal slices. Neuropharmacology. 34(8): 973-982

Pharmacological evidence for anandamide amidase in human cardiac and vascular tissues. International Journal Of Cardiology. 64(suppl. 1): S15-S22, Il 30

Pharmacological evidence for involvement of excitatory amino acids in aversive responses induced by intrathecal substance P in rats. Biological & Pharmaceutical Bulletin 16(9): 861-865

Pharmacological evidence for neurokinin receptors in murine neuroblastoma C1300 cells. Peptides (tarrytown). 16(2): 211-214

Pharmacological evidence for regulation of Na(+)-Ca++ exchange by Ca++/calmodulin-dependent protein kinase in isolated bovine adrenal medullary cells. Journal of Pharmacology and Experimental Therapeutics 270(1): 104-110

Pharmacological evidence for the existence of different subtypes of muscarinic acetylcholine receptors for phosphoinositide hydrolysis in neonatal versus adult rat atria. Journal of Lipid Mediators and Cell Signalling 12(1): 1-10

Pharmacological evidence for the involvement of calcium/calmodulin in serotonin 5-HT3 receptor-mediated cation permeability in NG 108-15 cells. Journal of Neurochemistry 62(6): 2224-2232

Pharmacological evidence for the involvement of endogenous alpha-MSH-like peptides in peripheral nerve regeneration. Peptides 16(2): 319-324

Pharmacological evidence for the involvement of sigma sites in DTG-induced contralateral circling in rats. Neuropharmacology. 34(1): 107-114

Pharmacological evidence for the involvement of the endogenous opioid system in the response to local inflammation in the rat paw. Pain. 60(1): 67-71

Pharmacological evidence for the persistent activation of ATP-sensitive K+ channels in early phase of reperfusion and its protection role against myocardial stunning. Circulation 92(8): 2266-2275

Pharmacological evidence for the presence of a beta-adrenoceptor-like agonist in the amphinomid polychaete Eurythoe complanata. Comparative Biochemistry & Physiology C Comparative Pharmacology & Toxicology. 104(2): 327-332

Pharmacological evidence for the presence of three distinct functional endothelin receptor subtypes in the rabbit lateral saphenous vein. British Journal Of Pharmacology. 114(8): 1529-1540

Pharmacological evidence for the putative existence of two different subtypes of PAF receptors on platelets and leukocytes; studies with yangambin. Journal Of Lipid Mediators & Cell Signalling. 17(1): 1-14

Pharmacological evidence for the release of galanin from rat stomach. Neuropeptides. 25(1): 47-50

Pharmacological evidence for tumor necrosis factor as a mediator of allergic inflammation in the airways. Journal of Pharmacology and Experimental Therapeutics 278(2): 847-853

Pharmacological evidence for two types of postsynaptic glycinergic receptors on the Mauthner cell of 52-h-old zebrafish larvae. Journal of Neurophysiology 77(5): 2400-2415

Pharmacological evidence of a role for platelet activating factor as a modulator of vasomotor tone and blood pressure. European Journal Of Pharmacology. 308(3): 287-294

Pharmacological evidence of alpha1D-adrenoceptors in the rabbit ventricular myocardium: Analysis with BMY 7378. British Journal of Pharmacology 122(8): 1541-1550, Dec

Pharmacological evidence of calcium-activated and voltage-gated potassium channels in human platelets. Clinical Science 93(3): 249-255

Pharmacological evidence of the disturbance of myocardial adrenoreactivity in chronic coronary ischemia. Fiziologiya Cheloveka 23(5): 58-62, Sept -Oct

Pharmacological evidence that NK-2 tachykinin receptors mediate hypotension in the guinea pig but not in the rat. Fundamental & Clinical Pharmacology. 10(4): 337-343

Pharmacological evidence that calcitonin gene-related peptide is implicated in cerebral autoregulation. American Journal of Physiology 266(1 Pt 2): H11-H16

Pharmacological evidence that calcium is not required for P-2-receptor-stimulated Cl- secretion in HT29Cl.16E. Journal of Membrane Biology 155(3): 239-246

Pharmacological evidence that cromakalim inhibits Ca-2+ release from intracellular stores in porcine coronary artery. Korean Journal of Physiology & Pharmacology 1(1): 27-34

Pharmacological evidence that endogenous ATP modulates cochlear mechanics. Hearing Research. 111(1-2): 42-54

Pharmacological evidence that flow- and potassium-induced contraction of rabbit facial vein may involve the same calcium entry pathway. Journal of Pharmacology and Experimental Therapeutics 268(1): 25-31

Pharmacological evidence that gold-protein-substance P complex activates neurokinin NK-1 receptors. Cellular Physiology & Biochemistry 5(2): 85-95

Pharmacological evidence that neurotensin mediates prolactin-induced activation of tuberoinfundibular dopamine neurons. Neuroendocrinology 68(2): 71-76

Pharmacological evidence that nitric oxide can act as an endogenous antipyretic factor in endotoxin-induced fever in rabbits. General Pharmacology. 26(4): 835-841

Pharmacological evidence that nitric oxide may be a retrograde messenger in the enteric nervous system. British Journal Of Pharmacology. 114(2): 428-432

Pharmacological evidence that nitric oxide mediates the antinociception produced by muscarinic agonists in the rostral ventral medulla of rats. Journal of Pharmacology and Experimental Therapeutics 269(2): 699-708

Pharmacological examination of receptors mediating contractile responses to tachykinins in airways isolated from human, guinea pig and hamster. Journal of Pharmacology and Experimental Therapeutics 267(1): 95-101

Pharmacological experiments on lowering the blood sugar lipids level of rhizoma Dioscoreae. Journal of Plant Resources & Environment 3(4): 59-60